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ABSTRACT 
In reported surveys of corn viruses from the 1970s, Maize chlorotic dwarf virus (MCDV) was the 
second most prevalent corn virus in the United States. MCDV is a member of the Waikavirus 
genus, viruses that are not well understood and have unique biological properties pertaining to the 
transmission of the virus. The MCDV protease shares sequence signatures with other 3C-like 
proteases, a group of proteases that typically utilize an active site with a catalytic triad consisting 
of cysteine or serine, aspartate or glutamate, and histidine. Additionally, these proteases often 
cleave themselves out of the viral sequence to allow for further maturation of the virus. Alignments 
of various waikaviruses and research on the catalytic activity of Rice tungro spherical virus, 
another Waikavirus, have led us to predict that H2667, D2704, C2798, and H2817 are the catalytic 
residues for the severe isolate of MCDV, MCDV-S, while R2532-Q2533 and A2839-A2840 are 
possible self-cleavage sites. We performed site-directed mutagenesis, agroinfiltration, and 
Western blotting to try to validate these possibilities. These experiments confirmed that D2704 
and C2798 are in fact catalytic residues in MCDV-S, while rejecting H2817 as a residue supporting 
catalysis. We also demonstrated that C2773 plays a role in the cleavage events, although the 
mechanism of this action is unknown and only speculated about. While self-cleavage sites were 
unable to be identified due to a lack of optimal detection methods, the mutants generated by this 
work provide opportunities for future studies to evaluate the role, if any, these sites exhibit in self-
cleavage.   
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INTRODUCTION 
 Maize chlorotic dwarf virus (MCDV) is a single-stranded RNA virus that causes stunting 
in the growth of corn and chlorosis of corn leaves (Figure 1A).1 Notably, MCDV is believed to be 
the second most prevalent corn virus found in the U.S.2 This virus is primarily found around the 
Atlantic coast stretching towards Texas, as well as near the Gulf of Mexico up to the southern parts 
of Ohio and other states in the Corn Belt.3 These are all areas of the U.S. that are major producers 
of corn and account for a large percentage of the 90 million acres of corn fields in the U.S.4 While 
the economic impact of these viruses is established, very little is known about the basic 
biochemistry necessary for infection, propagation, and impact on host physiology. This project 
seeks to resolve part of that gap by providing a mechanistic study of one of the key MCDV 
proteins, a protease that likely is critical to viral maturation. 
 MCDV was most prevalent in the 1970s, where data showed that about 76% of diseased 
corn in the U.S. was infected with the virus.3 Research regarding economic losses that may have 
been caused by the MCDV virus was conducted, but experiments identifying the exact loss due to 
a single pathogen are very difficult to do. There are also no published data indicating whether or 
not current hybrids of field corn are resistant to MCDV. However, MCDV is still found in 
Johnsongrass (Sorghum halepense), a weed that is prevalent in the U.S. and is often found near 
corn fields (Figure 1B).5 It has also recently been found near Roundup ReadyÒ fields as it has 
developed a resistance to this glyphosate herbicide.6 Johnsongrass is the overwintering virus 
reservoir that provides the inoculum for the infection of MCDV in corn seedlings. Because of this, 
the prevalence of Johnsongrass near corn fields may lead to the transmission of the virus to corn 
in the U.S. if the field corn is still susceptible.7 Experiments involving inoculation of the virus on 
corn seedlings has indicated that MCDV has the ability to decrease yield of corn crops by 72%.2 
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Therefore, if a corn variety is susceptible to MCDV, the impact on crop production would be 
detrimental. 
 
MCDV is a Waikavirus 
 MCDV was first identified in 1972,1 and particles were isolated and characterized in 1976.7 
MCDV is a member of the order Picornavirales, family Secoviridae (a picornavirus-like 
superfamily), and genus Waikavirus,8 and is joined in this genus by Rice tungro spherical virus 
(RTSV). RTSV is an economically significant virus that has caused major losses in rice crops for 
hundreds of years, and because of this established significance, RTSV has been studied more 
extensively than MCDV.9 Until recently, MCDV and RTSV were the only waikaviruses that were 
well-described by the literature; however, other viruses have been labeled as being members of the 
Waikavirus genus due to improvements in sequencing technologies. Blackcurrant virus A 
(GenBank accession nos. KJ572567-KJ572572) and Bellflower vein chlorosis virus are both 
recently identified Waikaviruses.10  
Both MCDV and RTSV are classified as phloem-limited, meaning that the virus is injected 
directly into the phloem of the plant by the vector. The virus then remains confined to phloem 
cells, unlike other viruses that can be delivered to the phloem but do not remain there. The insect 
vector for MCDV is the leafhopper Graminella nigrifrons (Figure 1C). The transmission of the 
virus by leafhoppers is unusual in that it can be transmitted immediately after the vector acquires 
it, and for an extended period of up to 2-3 days after acquisition.1,11 However, phloem-limited 
viruses are challenging to manipulate and propagate, which has prevented extensive research on 
these viruses despite the unique biological properties they exhibit and their impact on agriculture.7  
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Figure 1. (A) Leaves of corn that has been infected with MCDV, where chlorosis is visible. (Photograph courtesy of 
Ohioline entry by Jose L. Zambrano, Lucy R. Stewart, and Pierce A. Paul12). (B) Sorghum halepense, the 
overwintering host of MCDV that often grows near corn fields. (Photograph courtesy of Steve Hillebrand, U.S. Fish 
and Wildlife Service). (C) Graminella nigrifrons, the insect vector of MCDV. (Photograph courtesy of Scott Justis13). 
(D) Structure of an icosahedral virus capsid with three capsid proteins. 
	
Genomic Makeup of MCDV 
 The genomes of waikaviruses are monopartite, positive-sense, single-stranded RNA. 
MCDV is unique among other small, single-stranded RNA plant viruses because of its large, 
11,784 nucleotide genome and high virion molecular weight (8.8 x 106) being contained in just a 
30-nm isometric particle.14 This particle has an icosahedral structure made up of three capsid 
proteins (Figure 1D).15 The sequences of waikaviruses indicate that their genomes include a 
helicase, a 3C-like viral cysteine/serine protease, and an RNA-dependent RNA polymerase 
(RdRP).7 Waikaviruses are also speculated to have a long 5’ untranslated region that contains an 
internal ribosome entry site (IRES), a characteristic common among most picornaviruses and 
picornavirus-like superfamilies.16 IRES structures recruit host ribosomes in a manner that bypasses 
the need for a 5’ 7-methylguanosine cap to initiate mRNA translation and secures selective and 
efficient translation of the genomes of these viruses.7  
D	
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The MCDV genome contains a large open reading frame (ORF2) that encodes a 3458 
amino acid polyprotein, with a molecular mass of about 389 kDa (Figure 2).15 Three capsid 
proteins (CPs) are located near the N-terminus while the most C-terminal region contains the 
conserved RdRP domain from amino acids 3143-3154. Between these protein regions, from amino 
acids 1755 and 1818 of the polyprotein, is a helicase that is another characteristic of several 
picorna-like superfamily members and a 3C-like protease from amino acids 2613-2820.15 Finally, 
there are three proteins R78, R37, and R69, which are named for their predicted molecular 
weights.7 R37 and R69 currently have an unknown function, however recent research demonstrates 
that R78 exhibits silencing suppressor activity.17 
	
Figure 2. MCDV-S genome structure. This sequence is composed of 11784 nucleotides, and ORF2 translates the 
sequence to a 3458 amino acid sequence. Solid lines indicate approximate sequence locations. Capsid proteins are 
represented by CP, and three areas that code for protein of unknown functions are labeled (R78, R37, and R69). A 
predicted helicase domain is also included (Hel), as well as a predicted protease region (Pro). Open reading frames 
(ORF) are indicated. Adapted from Chaouch et al. (2004).15 
	
 Four isolates of MCDV and four isolates of RTSV have been sequenced. The MCDV 
isolates are MCDV-severe (MCDV-S), MCDV-type (MCDV-T),18 MCDV-mild (MCDV-
M/M1),19 and MCDV-Tennessee (MCDV-Tn).16 Sequences of the two major waikaviruses are not 
highly conserved, with isolates of RTSV and MCDV only demonstrating about 33-34% genomic 
nucleotide sequence identity. Additionally, there is only about 58-73% identity for the four MCDV 
isolates.20,21 Despite low sequence conservation between RTSV and MCDV, these viruses belong 
to the same genus and have similar viral properties. Therefore, we expect that studies of RTSV 
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should still be useful for providing insights into the mechanisms of MCDV infection and vice 
versa.  
 
Proteolytic Viral Processing 
 Picornavirus-like superfamily RNA viruses typically act through the translation of a 
polyprotein, which is then post-translationally cleaved by proteases to create the products 
necessary for viral activity. Polyprotein and protease sequences indicate that this is the case in 
MCDV as well. Although viruses often use proteases from the host cell for maturation of viral 
proteins early in the viral life cycle, the protease that catalyzes the cleavage events later on in 
maturation is usually part of the polyprotein that is being cleaved.22,23 This action may allow for 
better regulation of processing of the viral protein products due to both intermolecular and 
intramolecular cleavage. It is the cleavage of the polyprotein that contributes to the maturation of 
the virus, as the cleavage helps produce functional subunits. Some proteases cleave themselves out 
of the polyprotein sequence, in addition to the capacity to cleave at other sites in the polyprotein.24 
Additionally, research has demonstrated that after the protease has cleaved itself out of the 
sequence, it may still have the capacity to act as a protease and cleave the polypeptide later on in 
viral infection, furthering the maturation of the virus. For example, it has been speculated that a 
protein of Cardiovirus A, which is of the Picornavirales order, has been shown to have self-
cleavage properties and that the product of this self-cleavage, p22, may act as a protease and cleave 
the protein later on in viral processing.25 Additionally, recent research demonstrates that the 
MCDV protease can cleave at least some parts of the polyprotein by itself.17 This research aims to 
determine whether the protease of MCDV self-cleaves, and if so, where it self-cleaves.  
 
 
	 8 
3C-Like Viral Protease 
 Although the protease of MCDV-S has not yet been characterized, it is classified as a 3C-
like protease due to its similarity to other 3C-proteases.15 A 3C-like viral protease is a cysteine 
protease that utilizes a chymotrypsin-fold to position the active site residues that induce cleavage 
of proteins.26 While research has demonstrated that there is great similarity between the 
mechanism of cysteine proteases and trypsin-like serine proteases, proteases encoded by 
picornaviruses and picornavirus-like superfamilies typically contain cysteine active sites.15 Both 
cysteine and serine function as the nucleophile in a standard acid-base-nucleophile arrangement. 
In the case of 3C-like proteases, a histidine acts as a proton withdrawing group and deprotonates 
the thiol group of cysteine to promote nucleophilic attack on the carbonyl carbon of the target 
amino acid. A fragment of the substrate is released, and a thioester intermediate is formed that 
links the carboxy terminus of the substrate to the cysteine thiol. Then, the thioester bond is 
hydrolyzed to complete the cleavage and restore the catalytic residues. In addition, this mechanism 
usually includes an acidic residue that helps position and polarize the histidine residue (Figure 3).27 
Therefore, the active sites of typical 3C-like viral proteases consist of a catalytic triad of cysteine, 
histidine, and aspartic or glutamic acid.  
 The catalytic triad of MCDV-S has not been explicitly determined; however, for MCDV-
Tn it has been predicted to be histidine (2653), aspartate (2690), and cysteine (2784) based on 
sequence alignments and conservation comparisons with other picornavirus-like superfamily 
members.18 The virus protease regions of MCDV-S and MCDV-Tn have been shown to have 81% 
amino acid sequence identity, suggesting that the MCDV proteases may have conserved active site 
residues.15 Research on an isolate of RTSV (RTSV-A), showed that these three sites are also 
catalytic residues for this waikavirus as well, but with a glutamate instead of an aspartate at that 
	 9 
same position. RTSV-A research also demonstrates that a fourth residue may be included in the 
catalytic center – a second histidine (H2830).28 When RTSV and MCDV sequences are aligned, 
this fourth catalytic residue identified in RTSV-A is highly conserved across all other isolates of 
RTSV as well as MCDV, suggesting that they may utilize this fourth residue in their active sites 
as well (Figure 4). Sequence alignments, the protease amino acid segment of the MCDV-S 
genome, and the triads of typical picornaviruses can allow for the prediction of the approximate 
catalytic triad or quartet for MCDV-S.  
 
	
Figure 3. Schematic of the typical mechanism of a cysteine protease with a catalytic triad of histidine, aspartic acid, 
and histidine. The cysteine performs a nucleophilic attack on the carboxyl group of a nearby amino acid, causing 
cleavage of that amino acid and its neighbor. 
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Protease Cleavage Action in MCDV 
 3C-like viral proteases are typically shown to cleave at Q or E and G or S.24 Some 3C 
proteases, such as that of the human rhinovirus (HRV), cleave at more specific and larger 
sequences. For example, this protease cleaves at LEVLFQ/GP specifically.29 An analysis of 
multiple picorna-like superfamily members has indicated that most cleavages in these polyproteins 
simply occur between Q residues and residues with small amino acid side chains, such as M, L, or 
A.24 Most RTSV cleavage sites have also been defined as following a Q residue.30 Furthermore, 
the most common amino acid at the -1 position of the cleavage sites in Waikaviruses specifically 
is Q,8 as indicated by known MCDV and RTSV cleavage sites. Therefore, the self-cleavage site of 
the MCDV protease likely follows this same pattern. 
 Some research has been conducted on the cleavage sites specifically in MCDV isolates. 
Cleavage locations of the three capsid proteins (CPs) in MCDV-S have been identified as Q-V for 
CP2, Q-L for CP3, and Q-M for CP1 (Figure 5).15 This verifies previous findings that the protease 
often cleaves between a Q residue and another amino acid with a small side chain. Other cleavage 
sites have been identified that are also conserved across many isolates of MCDV. In addition to 
the three CPs, the MCDV polyprotein is post-translationally cleaved into six products: P51, P27, 
and approximately four other products that have not been explicitly identified.16,17 
 
	
Figure 5. Illustration of the known cleavage sites in the amino acid sequence of MCDV for the capsid proteins (CPs), 
demonstrated by yellow triangles.15 
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 Most viral proteases release themselves from the polyprotein structure they are a part of by 
autocatalytic cleavage at the borders of the protease region.24 Thole and Hull (1998) have 
demonstrated this in the Waikavirus RTSV protease, with cleavages occurring at both the N- and 
C-terminal ends of the proteolytic domain.31 However, they also stated that an inefficient cleavage 
site at either end is possible, suggesting that there may be other processing events involved in the 
cleavage of the protease from the polyprotein.31 Sekiguchi et al. reported an internal cleavage site 
of the RTSV protease using an in vitro experimental system.32 Self-cleavage action of the protease 
in MCDV has not been identified as it has not been tested before. Notably, none of the RTSV self-
cleavage sites are conserved at the same positions in MCDV-S (Figure 4). They are semi-
conserved, in that the neighboring amino acids are conserved or similar, but the typical Q residue 
at the -1 position of the cleavage site is not conserved in MCDV. This could indicate the protease 
self-cleavage site of MCDV might be at a different position nearby, rather than lining up exactly 
with the identified RTSV location. 
 Identifying self-cleavage of the 3C-like protease of MCDV would allow for a greater 
understanding of the proteolytic processing of MCDV and a deeper knowledge of the understudied 
viruses MCDV represents. In the long term, investigating the protease mechanism and how it can 
be inhibited may also allow for the information to be extrapolated to other viruses that impact 
agriculture and therefore could influence production of control methods.  
Following analysis of conservation demonstrated in sequence alignments and investigation 
of other characterized viral proteases, we hypothesize that the MCDV protease behaves like other 
3C-like proteases and uses the catalytic center of H2667, D2704, C2798, and H2817. Therefore, 
mutations to these residues would prevent the protease’s ability to cleave known target substrates. 
In addition, two other residues (D2692 and C2773) are going to be tested due to their location in 
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the sequence being in close proximity to those residues that were hypothesized as being catalytic, 
but these two residues are not hypothesized to have an effect on the cleavage activity of the 
protease. We also aim to determine if R2532-Q2533 and A2839-A2840 are self-cleavage sites, as 
sequence alignments with RTSV indicate that they are possibilities, despite these residues being 
abnormal for 3C-like protease cleavage sites (Figure 4). To allow us to further characterize MCDV, 
we will utilize site-directed mutagenesis to mutate predicted catalytic residues and perform 
agroinfiltration, an in vivo assay for expressing proteins in plants.  
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MATERIALS AND METHODS 
Site-Directed Mutagenesis Pipelines 
	
Figure 6. Schematic outlining the various mutagenesis pipelines attempted and what steps were successful or not 
successful for each strategy. 
  
First Mutagenesis Strategy: Enzymatic Inverse PCR 
 Site-directed mutagenesis using enzymatic inverse Polymerase Chain Reaction (PCR)33 
was performed for each predicted catalytic residue, two additional potential catalytic residues, and 
the two predicted self-cleavage sites of the “superpreprotease” (previously designed by Kristen 
Willie, USDA-ARS; aa. 2399-2931 in the MCDV-S sequence; GenBank Accession no. 
AY362551) in a pGEM-T Easy vector (Promega). PrimeSTAR polymerase (TaKaRa) was used in 
50 µl reactions. The forward and reverse primers used in each PCR reaction overlap one another 
and are outlined in Table 1, as well as their assigned reaction number and which residue they are 
targeting. Each primer introduces a NheI restriction site at the residues targeted for mutagenesis, 
and this site is used for cleavage and re-ligation of the PCR products to obtain mutant clones and 
to confirm the desired mutation. The products were then desalted and purified using a DNA Clean 
Enzymatic
Inverse PCR
DpnI 
Digestion &
 High 
Efficiency
Cells
PCR NheI Digestion
PCR DpnI Digestion Transformation Sequencing
Q5 Site-
Directed
Mutagenesis
& new primers
PCR KLD Transformation Sequencing Transform intopCASS vector
Ligation SequencingTransformation
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& Concentrator kit (Zymo Research), and concentrations were measured using NanoDrop 
(Thermo Fisher Scientific). 
 
Table 1. Primers designed for mutagenesis of predicted catalytic residues and cleavage sites of MCDV-S SPP. Bolded 
nucleotides indicate the introduction of the NheI restriction site. F indicates forward primer, while R indicates reverse 
primer. 
Mutation 
No. 
Mutation 
Site 
Primers 
1 R2532-
Q2533 
F:     5’ –CTT TGG GCT AGC AAC GCT GCA AAT  – 3’ 
R:     5’ – GTT GCT AGC GGT TTC TCG TAT CTC   – 3’ 
2 H2667 F:     5’ – CCA GCC GCT AGC TTG GAA GCT TTA– 3’  
R:     5’ – TAA AGC TTC CAA GCT AGC GGC TGG GCA– 3’ 
3 D2692 F:     5’ – CTC ACT TTT GCT AGC AGT AGA GTG  – 3’ 
R:     5’ – TCT ACT GCT AGC AAA AGT GAG CTT  – 3’ 
4 D2704 F:     5’ – AGC CAG GCT AGC AAG ATG GTT TGG  – 3’ 
R:     5’ – AAC CAT CTT GCT AGC CTG GCT ATT  – 3’ 
5 C2773 F:     5’ – ACG GGT GCT AGC TCC ATG ATG GGC  – 3’ 
R:     5’ – CAT CAT GGA GCT AGC TGG CGT GGG  – 3’ 
6 C2798 F:     5’ – GGA GCT AGC GGT GGG TTA ATC CTG AGA  – 3’ 
R:     5’ – GAT TAA CCC GCT GCT AGC TCC ATC  – 3’ 
7 H2817 F:     5’ – ATC GCT AGC GCT GGA AGC CAG AAT   – 3’ 
R:     5’ –TAG CGA TCG CGA CCT TCG GTC TTA GTG  – 3’ 
8 A2839-
A2840 
F:     5’ – GAT CTA CGG GCT AGC GTG GCG AGA TTG  – 3’ 
R:     5’ –  TCT CGC CAC GCT AGC CCG TAG ATC TTC  – 3’ 
 
The PCR product was digested using 50 µl reactions with NheI, CutSmart (NEB), and as 
close to 500 ng of DNA as possible. These reactions were incubated overnight in a 37°C water 
bath. All were cleaned using the DNA Clean & Concentrator kit prior to ligation using T4 DNA 
Ligase (NEB) and an overnight incubation at 16°C. 
 
Second Mutagenesis Strategy: DpnI Digestion and High Efficiency Cells 
 A second site-directed mutagenesis strategy was performed for each predicted catalytic 
residue and cleavage site. PrimeSTAR polymerase and buffer were once again used in 50 µl 
reactions using the primers listed in Table 1 to introduce the same mutation. A new cycling 
program (see Table 2) was used as well, which employs longer denaturation, annealing, and 
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polymerization steps, while decreasing the total number of cycles to 16. These new cycling 
conditions were inflicted to ensure there was enough time for proper denaturation, annealing, and 
polymerization. 
 
Table 2. Cycling conditions for second site-directed mutagenesis strategy. 
Segment Cycles Temperature Time 
1 1 95°C 30 seconds 
2 15 95°C 30 seconds 
55°C 1 minute 
68°C 8 minutes 
3 1 94°C 1 minute 
55°C 1 minute 
72°C 10 minutes 
 
Once PCR was completed, 0.5 µl of DpnI was added to each reaction and the mixture and 
was incubated at 37°C for one hour. The digested reaction was then transformed directly into 10-
Beta Competent E. coli High Efficiency cells (NEB). These cells were then plated on Luria Bertani 
(LB: 0.17 M NaCl, 0.5% yeast extract, 1.0% tryptone, 1.5% agar) media plates containing 
ampicillin (100 µg/µl). Plates were incubated overnight at 37°C. Colonies were picked the next 
day, added to about 4 ml of LB broth containing ampicillin, and a Colony PCR using GoTaq 
(Promega) and the primer pair DM47+DM48 (Table 4) was also performed to confirm presence 
of the desired plasmid. Those colonies that did demonstrate presence of the plasmid were grown 
on a shaker at 220 rpm overnight at 37°C. A plasmid miniprep was then performed using 
instructions outline in the Zymo Research Plasmid Miniprep protocol, and samples were sent for 
sequencing (Elim Biopharm).  
 
Third Mutagenesis Strategy: Q5â Site-Directed Mutagenesis (NEB) 
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 A third mutagenesis strategy was utilized following the Q5â Site-Directed Mutagenesis kit 
protocol (NEB). An NheI restriction site was still introduced as the mutation, however new primers 
were designed using the NEBaseChanger tool offered through NEB. The primers were designed 
to not overlap, but instead line up end-to-end, with the mutation in the middle of the forward 
primer. New NEB primers are listed in Table 3. 
 
Table 3. Primers designed using NEBaseChanger for the Q5â Site-Directed Mutagenesis kit. Bolded nucleotides 
indicate location of the introduced NheI site. F stands for forward, while R stands for reverse. 
Reaction 
No. 
Mutation 
Site 
Primers 
1 R2532-
Q2533 
F:     5’ – ACGACTTTGGGCTAGCAACGCTGCAAATAAAGG – 3’ 
R:     5’ – ATCTCTTCCAAGGTAGATG – 3’ 
2 H2667 F:     5’ – TTGCCCAGCCGCTAGCTTGGAAGCTTTAG – 3’  
R:     5’ – ACAACTATAGTGCCTATAAG – 3’ 
3 D2692 F:     5’ – GCTCACTTTTGCTAGCAGTAGAGTGACTC – 3’ 
R:     5’ – TTGATAACCAATGAGAAGC – 3’ 
4 Q2703 F:     5’ – GAATAGCCAGGCTAGCTTGATGGTTTGGGATCTTGG – 3’ 
R:     5’ – ACGAGAGTCACTCTACTTG – 3’ 
5 C2773 F:     5’ – TCCCACGGGTGCTAGCTCCATGATGGG – 3’ 
R:     5’ – TTCTGAGTATTTGCCCTAATC – 3’ 
6 C2798 F:     5’ – TGATGGATTCGCTAGCGGGTTAATCCTGAGAG – 3’ 
R:     5’ – AGAGAGAACATTTGATATCG – 3’ 
7 H2817 F:     5’ – CGTCGGGATCGCTAGCGCTGGAAGCC – 3’ 
R:     5’ – ACCTTTCTCACCATGTTTG – 3’ 
8 A2839-
A2840 
F:     5’ – AGATCTACGGGCTAGCGTGGCGAGAT – 3’ 
R:     5’ – TCGGCAATAAGGCACTCT – 3’ 
 
 PCR was performed using Q5 Hot Start High-Fidelity Master Mix in 25 µl reactions. The 
cycling conditions used followed those outlined in the kit protocol. Following PCR, a 10 µl Kinase-
Ligase-DpnI (KLD) reaction was set up (1X KLD Reaction Buffer, 1X KLD Enzyme mix, 1 µl 
PCR product, 3 µl ddH2O). The reaction was incubated at room temperature for 5 minutes. A 5 µl 
aliquot of this reaction was then transformed into NEB High Efficiency 5-alpha Competent E. coli, 
plated on ampicillin selection plates, and grown overnight at 37°C. Colonies were picked the 
following day, added to about 4 ml of LB broth containing ampicillin, and grown on a shaker at 
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220 rpm at 37°C overnight. A plasmid miniprep was then performed, a diagnostic digestion was 
done with EcoRI and NheI, which digested at the ends of the protease insert as well as at the 
mutation site, and chosen samples were sent for sequencing (Elim Biopharm). 
Inserting Mutants Into pCass Vector 
	
Figure 7. Cloning strategy employed in cloning mutants into Agrobacterium vector, pCass. 
	
	
 The protease mutants were inserted into a pCass vector using a Gibson Assembly strategy, 
where overlapping DNA fragments are subjected to 5’ endonucleases, the fragments anneal, DNA 
polymerase extends the 3’ ends, and DNA ligase seals any nicks.34 Two rounds of PrimeStar PCR 
were performed on mutants using primer pairs LRS317+LRS318 and DM47+DM48 (Table 4) to 
add epitope tags and prepare the sequence for insertion into the pCass vector. pCass was digested 
with NcoI and SacI in a 50 µl reaction. PCR products were cleaned using the DNA Clean & 
Concentrator kit, and then joined with the digested pCass vector using the NEBuilderâ HiFi DNA 
Assembly Master Mix kit (NEB) with a 1:3 vector to insert ratio. Following assembly, 2 µl of the 
reaction mixture was transformed into NEB High Efficiency 5-alpha Competent E. coli, plated on 
kanamycin plates, and grown overnight at 37°C.  
 
	 19 
Table 4. Primer sequences for pCass vector insertion and colony PCR. Primers were designed previously in the 
Stewart lab. 
Primer 
Name 
Region Sequence 
LRS317 SP6PreProF CATCATTATTTAGGTGACACTATAGAACAGACCACCATGGATC
TGTACGACGATGACGATAAGTCCAAACCAGCAAGGAGGC 
LRS318 MycPreProR tcactaCAGATCCTCTTCTGAGATGAGTTTTTGTTCAATCCCTA
TTTCTAGATTATTAACCT 
DM47 pCassXpressF TTCACCATTTACGAACGATAGCCATGGATCTGTACGACG 
DM48 cMycpCASSR CAGCGTACCGAATTCGAGCTCTTACAGATCCTCTTC 
 
 Colonies were picked and added to about 4 ml of media containing kanamycin. 
Additionally, the colonies were screened using a GoTaqâ PCR (Promega) and DM47+DM48. 
Colonies that did not yield a PCR product with test primers were discarded, and positive colonies 
were grown overnight while shaking at 37°C. A plasmid miniprep was performed, and samples 
were sent for sequencing. Note that mutant 2 did not yield positive colonies, and therefore was not 
used for further experiments.  
 
 
Agroinfiltration and Expression 
 Agrobacterium tumefaciens, strain C58C1, competent cells were transformed with 1 µg of 
mutant plasmid DNA. Transformation conditions consisted of incubating the cells on ice for 5 
minutes, submerging the cells in liquid nitrogen for 5 minutes, and incubating the cells at 37°C for 
5 minutes. Clones were selected on LB media plates with the antibiotics Kanamycin (50 µg/µl), 
Rifampicin (50 µg/µl), and Gentamycin (50 µg/µl), which were incubated for 72 hours at 28°C. 
Individual colonies were picked and grown on a shaker at 220 rpm at 28°C in 3 ml LB broth 
supplemented with the aforementioned antibiotics for 24 hr. The overnight cultures were pelleted, 
washed, and resuspended in inoculation buffer containing 10 mM MgCl2, 10 mM MES, and 150 
µM acetosyringone. Resuspended cultures were then incubated at 28°C for one hour. 
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 To evaluate the potential catalytic residue mutants, mutants 3-7 were combined with equal 
volumes of R78. P19, a strong silencing suppressor of tomato bushy stunt virus (TBSV) and is 
used here to suppress gene silencing, was also co-infiltrated at an equal volume with each sample. 
Controls included wild type SPP, R78 (tagged with hemagglutinin tag (HA) at the C-terminal), 
non-inoculated plant, and GFP HA. To evaluate the potential self-cleavage location, mutants 1 and 
3-8 were combined with an equal volume of P19. Controls included wild type SPP and non-
inoculated plant. Samples were infiltrated into leaves of Nicotiana benthamiana plants grown in 
Fafards 3B (Sun Gro Horticulture) soil medium at greenhouse conditions of 24-27°C, 70% 
humidity, and natural lighting for 2-3 weeks.  
 Samples were collected for Western blot 2 days post-infiltration. Approximately 0.09 g of 
each leaf sample was harvested, flash frozen, and ground in liquid nitrogen. The sample was then 
ground in 500 µl RIPA buffer (1X RIPA (EMD Millipore), 100 mM PMSF (Gold Bio), 0.1 M 
DTT (Invitrogen), one Protease Inhibitor Cocktail tablet (Roche, cOmplete Mini)). Samples were 
spun at 14500 rpm and 4°C for 20 minutes. The supernatant was then combined with an equal 
volume of 2X Laemmli sample buffer (Bio-Rad) and boiled for 5 minutes. The cell lysates were 
electrophoresed on 4-20% Mini-PROTEAN TGX gels (Bio-Rad) in Tris/Glycine/SDS buffer (25 
mM Tris(hydroxymethyl)aminomethane pH 8.8, 200 mM glycine, 0.1% sodium dodecyl sulfate) 
at 100 V for 150 minutes. A Precision Plus Protein Dual Color Standard (Bio-Rad) and Magic 
MarkÔXP Western Protein Standard (Invitrogen) also was loaded alongside cell lysates.  
Proteins were electro-transferred to 0.45 µm nitrocellulose (Amersham) membranes in 25 
mM Tris (pH 8.8), 200 mM glycine buffer with 10% methanol overnight at 30 V at 4°C. 
Membranes were blocked with 5% nonfat dry milk in TBS buffer (50 mM Tris pH 7.5, 150 mM 
NaCl) for 2 hours and washed one time for 5 minutes in TBS with 1% Tween 20 (TBST). 
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Membranes with samples infiltrated with R78 and p19 were incubated at room temperature for 1.5 
hours with 1:2000 polyclonal rabbit HA IgG antibody (Abcam) or 1:500 Anti-R78 (Chaouch et 
al., 2004) in TBST with 1% nonfat dry milk. Membranes with samples just infiltrated with p19 
were incubated at room temperature for 1.5 hours with either 1:5000 monoclonal rabbit Xpress 
IgG antibody or 1:5000 monoclonal rabbit myc IgG antibody (Abcam). All membranes were then 
incubated with 1:5000 Goat Anti-Rabbit IgG H&L (HRP) (Abcam). Proteins were visualized by 
chemiluminescence using ClarityÔ Western ECL Blotting substrates (Bio-Rad) on a ChemiDoc 
XRS System (Bio-Rad). 
 
Protein Structure Modeling 
 A protein structure model was created using SWISS-MODEL (ExPASy). The target 
sequence used was the superpreprotease sequence of MCDV-S, and the default search parameters 
were used. The program identified the sequence to have a 22.42% sequence identity with model 
sequence Picornain 3C, RNA-directed RNA polymerase). The structure was then annotated using 
UCSF Chimera.  
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RESULTS 
 
Mutagenesis Strategies 
First Mutagenesis Strategy: Enzymatic Inverse PCR 
 The first mutagenesis strategy (Figure 6) never yielded appropriate concentrations of DNA 
following digestion of the mutants with NheI prior to ligation. When the digestion product was run 
out on a gel, no bands were visualized, except for Mutant 5, which demonstrated a band at about 
4 kb (Figure 8A). This method depended on introducing a restriction enzyme site in both primers 
to provide an overhang for the two ends of the plasmid to ligate once the PCR product was digested 
with the enzyme. However, low yields following digestion never allowed for ligation to be 
possible. 
 
Second Mutagenesis Strategy: DpnI Digestion and High Efficiency Cells 
 A new mutagenesis strategy was attempted (Figure 6), which used the same primers but 
involved a DpnI digestion prior to the NheI digestion to eliminate parent plasmids. This was 
followed by transformation into ultra-competent cells, where ligation occurs via the cell’s 
machinery. This was intended to eliminate the chances of parent plasmids being transformed while 
also eliminating the ligation step. The PCR reaction was successfully transformed into competent 
cells, and colony PCR and diagnostic digestion of Mutant 1 to linearize the plasmid indicated that 
mutagenesis was successful. Following digestion, a band was seen around the size of the plasmid 
and insert (approximately 4.6 kb), indicating successful incorporation of the insert into the 
plasmid. However, sequencing showed that the insert did not ligate appropriately, as the sequence 
was incomplete and disordered.  
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Figure 8. Gel electrophoresis results of the failed mutagenesis strategies. Gel electrophoresis conditions were 50 V 
for 60 minutes on 1% agarose gel stained with ethidium bromide alongside a 1 Kb Plus DNA Ladder (Thermo Fisher 
Scientific) (A) Gel demonstrating digestion of the mutants with NheI prior to ligation in the first strategy. Digested 
(abbreviated Dig) and undigested mutants (Mut) were run alongside each other in an alternating fashion. (B) 
Diagnostic digestion of ten Mutant 1 minipreps obtained by performing the second strategy. 
	
Third Mutagenesis Strategy: Q5â Site-Directed Mutagenesis 
 The use of the Q5â Site-Directed Mutagenesis kit (NEB) proved to be the most successful 
mutagenesis strategy, as all eight mutations (Mutant 1 to Mutant 8) were achieved with this 
method. We decided to try this kit for a variety of reasons. First, it involved designing new primers 
that were designed end-to-end with the mutation in only the forward primer, which is claimed to 
help ensure exponential amplification. Additionally, this kit employs a Kinase-Ligase-DpnI (KLD) 
mix that performs all of these enzyme’s functions in a quick, 5-minute reaction. This is intended 
to quickly re-circularize the plasmid prior to transformation to hopefully eliminate unintended 
ligations or rearrangements. 
Confirmation of successful incorporation of the desired mutation was indicated by 
diagnostic digestion of the minipreps (Figure 9A and B). Diagnostic digestion results of multiple 
reactions to produce Mutant 1 (1.1-1.8) with EcoRI and NheI are shown in Figure 9A. Digestion 
of mutant 1 should yield bands at 461 bp and 1310 bp, which is seen with both Mutation 1.2 and 
A	 B	
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1.8. All other lanes have bands at 3000 bp and 1700 bp. Controls indicate that the uncut pGEM-T 
Easy vector, the cut pGEM-T Easy vector, and the cut template could account for the bands seen 
at these sizes.  
Diagnostic digestion results of mutations 2-8 can be seen in Figure 9B. Digestion of 
mutation 2 with EcoRI (to cleave at the ends of the sequence) and NheI (to cleave at the mutation) 
should yield bands at 869 and 902 bp. Because these sizes are so similar, it is likely that the single 
band seen around 800 bp accounts for both of these digestion products (2.5, 2.2, 2.4). Mutation 3 
should have bands show at 944 bp and 827 bp, which are seen in 3.1, 3.5, and 3.2. Mutation 4 
should have bands at 977 and 794 bp, which are seen in 4.6 and 4.3. Mutation 5 should have 
digestion products of about 1187 and 584 bp in length (5.6, 5.3). Mutation 6 should have bands 
shown at 1282 and 509 bp (6.6, 6.7). Mutation 7 should have bands at 1319 and 452 bp (7.4, 7.7). 
Finally, mutation 8 should have digestion products of 1385 and 386 bp in length (8.1, 8.2, 8.4). 
Minipreps that indicated inclusion of the mutation after diagnostic digestion with EcoRI and NheI 
were sent for sequencing which confirmed the correct mutations. Refer to Appendix A for 
sequencing results. 
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Figure 9. Gel electrophoresis of diagnostic digestion of Mutations 1-8 with EcoRI and NheI. Electrophoresis 
conditions were 30 minutes at 100 V on 1% agarose gel stained with ethidium bromide. 1 kb GeneRuler and 100 bp 
GeneRuler were used as the ladders. (A) Diagnostic digest of eight minipreps from Mutation 1, as well as controls. 
Lanes 1-5 consist of ladder, uncut Mutant 1.1, cut Mutant 1.1, cut Mutant 1.2, and uncut Mutant 1.2 respectively. 
Lanes 6-11 contain cut minipreps 1.3-1.8. Lanes 12-15 contain controls: uncut pGEM-T EZ, cut pGEM-T EZ, uncut 
SPP template, and cut SPP template respectively. (B) Diagnostic digest of minipreps from Mutations 2-8 are in lanes 
2-22, and controls are in lanes 23-26.  
A	
B	
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Identification of Protease Catalytic Residues 
 To identify the catalytic residues of the protease region of MCDV, mutants 2-7 were 
designed to mutate possible catalytic sites (Refer to Table 3 for mutations). Mutant 2 was unable 
to be used, however, as there was difficulty cloning it into the pCass vector. Those protease 
mutants that were successfully cloned (Mutants 3-7) were infiltrated into Nicotiana benthamiana 
with R78, a polyprotein that has been shown to be cleaved by the protease into two smaller proteins 
of 51 and 27 kDa.17  
 Following cleavage of R78 in these experiments, the C-terminal 27 kDa protein is seen in 
the lane containing wildtype SPP and R78, which migrates aberrantly (at 32 kDa) on SDS-PAGE 
gels as documented previously.17 Alternatively, uncleaved R78 would yield a single band at 
approximately 80 kDa, due to the size of the protein and the HA-tag, which is seen in the lane 
containing only R78. This band is also running slightly higher than expected, but once again 
matches previous research regarding R78 cleavage by Stewart et al.17 Mutants 4-6 all blocked the 
cleavage of R78 by the protease, as these lanes resemble that of the R78 by itself and no cleavage 
products are seen. However, mutants 3 and 7 did not block the cleavage of R78 as the p27 cleavage 
product is seen in both of these lanes. Notably, mutant 3 demonstrates complete cleavage of R78, 
as no band is seen at the molecular weight for R78, despite a faint band appearing for mutant 7 
and the wildtype SPP-R78 combination.  
 The GFP control with an HA tag was seen in Figure 10A, which was incubated with an 
anti-HA antibody. This control indicates successful infiltration as well as expression in the plant. 
It also serves as a positive control for the HA tag. Additionally, the non-inoculated plant control 
exhibits only a single band, indicating that this band is background in all the samples. It appears 
to correspond to Ribulose-1,5-bisphosphate carboxylase/oxygenase (RuBisCO). RuBisCO is an 
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enzyme that plays a role in photosynthesis, and is the most abundant protein in the world.35 Many 
researchers have also found it to cross-react with antisera when working with Western blotting.36 
Finally, a band is seen at about 45 kDa for mutants 4-6 and R78 on the anti-HA blot, but not the 
anti-R78 blot, but this protein is unknown. It is likely background, as it also appears in the control 
lane containing only R78. 
 
Table 5. Mutants 2-7 wildtype sequence and mutant sequence. All mutations were done by incorporating an NheI 
restriction enzyme site, which translates to amino acids AS.  
 Wildtype Mutant Mutation Made 
Mutant 2 CPAH2667YLEA CPAASLEA HY2667AS 
Mutant 3 LFTD2692PSRV LFTASPSRV DP2692AS 
Mutant 4 TIQQD2704LKG TIQASLKG QD2704AS 
Mutant 5 PTGC2773YSMM PTGASSMM CY2773AS 
Mutant 6 DGFC2798GGLI DGFASGLI CG2798AS 
Mutant 7 VGIH2817VAGS VGIASAGS HV2817AS 
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Figure 10. Western blots showing the cleavage of MCDV-S R78 by the viral 3C-like protease mutants. The protease 
mutants were infiltrated with R78 in leaves of Nicotiana benthamiana and leaves were collected 48 hours post-
infiltration. (A) Western blot was performed using anti-HA antiserum (Abcam). A Magic Mark ladder (Invitrogen) 
was used as the standard. (B) Western blot was performed using anti-R78 antiserum (Chaouch et al., 2004). A Magic 
Mark ladder (Invitrogen) was used as the standard.  
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Identification of Protease Autocatalytic Cleavage Sites 
 Mutants 1 and 8 were designed to investigate possible autocatalytic cleavage sites of the 
3C-like protease of MCDV-S (refer to Table 6 for mutations). These mutations were unable to be 
properly investigated, as the assay for detecting the protease in a Western blot using Xpress and c-
Myc tags was unsuccessful. The protease had been tagged with Xpress and c-Myc tags at the N- 
and C-terminal ends respectively, so the antiserum for each of those should have picked up the tag 
at one end of the protease. However, no detection was observed. Additionally, the anti-protease 
antibody has proven to be difficult to produce, and was not able to be produced in time for this 
project, delaying our ability to design a new assay to investigate the potential self-cleavage sites 
(Sherry Xu, GenScript, personal communication).  
 
Table 6. Mutants 1 and 8 wildtype sequences and mutant sequences. All mutations were done by incorporating an 
NheI restriction site, which corresponds to amino acids AS.  
 Wildtype Mutant Mutation Made 
Mutant 1 LEEIRLWR2532Q2533NAA LEEIRLWASNAA RQ2532AS 
Mutant 8 LIAEDLRA2839A2840VAR LIAEDLRASVAR AA2839AS 
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DISCUSSION 
Mutagenesis Troubleshooting 
Three strategies were attempted to achieve the desired mutants. The third strategy, which 
utilized a Q5â Site-Directed Mutagenesis kit from NEB, was completely successful as all eight 
mutants were created. However, the first two attempts utilizing different combinations of Inverse 
PCR, ultra-competent cells, and DpnI digestion were not successful. Primers for Q5â Site-Directed 
Mutagenesis were designed to have the 5’ ends back-to-back and with the mutation incorporated 
in the middle of the forward primer to ensure that there is strong exponential amplification. PCR 
is followed by a Kinase-Ligase-DpnI (KLD) treatment, which allows for a rapid circularization of 
the product and removal of the template DNA prior to transformation (Q5Ò Site Directed 
Mutagenesis Kit Instruction Manual). 
 Little research has been conducted regarding the production of viral clones. Viral infectious 
clones have been found to be particularly difficult to produce, and this problem is most often seen 
with positive-sense RNA viruses.37 This is likely the reason why three strategies had to be tried 
prior to successfully cloning the viral protease sequence. Virus-derived clones often are unstable 
in bacteria or toxic to the bacteria they are transformed in.37 A low yield is often reported, and 
could account for the results seen with the first strategy of Inverse PCR. This low yield could 
possibly be due to the PCR strategy not having completely exponential amplification. 
Additionally, various researchers have observed spontaneous rearrangements when cloning 
viruses,38 an observation that matches what we saw after sequencing the plasmid obtained from 
the second strategy. Since the KLD treatment utilized in Q5â Site-Directed Mutagenesis prior to 
transformation allowed for a more rapid DpnI digestion of the parent plasmids and ligation of the 
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product plasmid, it may have helped prevent the plasmid from rearranging once it had been 
transformed.  
In addition to our difficulties in developing mutant clones of the protease, the company 
that was designing a custom antibody for the MCDV-S protease was also experiencing difficulties 
(GenScript). The expression level of the protein was very low, so the process of producing the 
antibody was stalled because of this, and delivery of the protease was delayed by over two months 
(Sherry Xu, Genbank, personal communication). The Stewart lab has also experienced difficulty 
working with mutagenesis of the MCDV-S protease sequence, and often observes low cloning 
efficiencies indicative of E. coli toxicity in prior research (Dr. Lucy Stewart, personal 
communication).  
 
Identification of Catalytic Residues in the Protease of MCDV-S 
 The genus Waikavirus consists of a growing number of viruses that infect plants and have 
been shown to have devastating effects on their hosts. A better understanding of the mode of 
infection, and specifically the proteolytic processing mechanism, of the currently identified viruses 
belonging to this genus will allow for a better understanding of the basic biology of this virus. This 
knowledge could also be extrapolated to the wider set of waikaviruses and viruses of the picorna-
like superfamily. This research sought to specifically look at the protease in Maize chlorotic dwarf 
virus and its catalytic action, including its active site residues and self-cleavage sites. 
 These results demonstrate that D2704, C2773, and C2798 play a role in the protease’s 
ability to cleave other proteins, specifically R78, as all three mutations eliminated the appearance 
of p27. C2798 was hypothesized to be a catalytic residue due to it being highly conserved among 
waikaviruses (Figure 4), while also being identified as a catalytic residue in RTSV-A and 
speculated to be one in MCDV-Tn.28,18 Additionally, D2704 was hypothesized to be a catalytic 
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residue because of its predicted role in MCDV-Tn, and because it is conserved across the four 
MCDV isolates.18 It also neighbors a very highly conserved glutamine, Q2703, and aligns with the 
glutamate catalytic residue of RTSV-A, E2717.28 However, H2817, another highly conserved 
residue that was also identified as a catalytic residue in RTSV-A, does not seem to play a role in 
catalytic activity as mutating this residue did not disrupt the protease’s ability to cleave R78. 
Furthermore, mutating D2692, a residue that is not highly conserved but is in the same general 
location as other predicted catalytic residues, did not have any effect on the cleavage event either.  
 
	
Figure 11. The predicted catalytic triad of the 3C-like protease of MCDV-S is H2667, D2704, and C2798. C2773 
seems to be playing a role in the folding of the structure, and is predicted to be forming disulfide bonds with 
neighboring cysteines. Green residues are those that have been shown to diminish cleavage ability of the protease 
when mutated. The yellow residue, H2667, was unable to be tested due to difficulties cloning, but is believed to 
complete the catalytic triad. The model structure was made using SWISS-MODEL, and the protease sequence has a 
22.42% sequence identity with the model sequence (Picornain 3C, RNA-directed RNA polymerase). The structure 
was then annotated using UCSF Chimera. 
 
A model protein structure was created (Figure 11), which helped verify the role of D2704 
and C2798 as catalytic residues due to their proximity to one another in the folds of the protein. 
Additionally, the residue that was unable to be tested, H2667, is also in close proximity to these 
residues, and therefore likely completes the catalytic triad. Of course, this is just a model and 
cannot be totally relied on since the exact structure of the protease of MCDV-S has not been 
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characterized; however, it does provide some insight to the folding of this protease as it was made 
based on sequence identity with other 3C proteases. 
 An unexpected result was that two cysteine residues just 25 amino acids apart both had an 
effect on the catalytic activity of the protease. The assay was replicated three times, and the same 
results were demonstrated in all replicates. In addition to mutating the highly conserved C2798, 
mutating C2773 also abolished the protease’s ability to cleave R78. When analyzing the model 
protein structure of the protease (Figure 11), it seems that C2798 does play a role in the active site, 
while C2773 does not. Identifying C2798 as a catalytic residue also complements research on 
previously identified catalytic residues in other waikaviruses.28  
There are various possible, but so far untested, explanations for why the C2773 mutation 
might be affecting the proteolytic cleavage events. The first is that 3C-like proteases utilize a 
chymotrypsin fold to induce the cleavage of their target proteins.26 Enzymes in the chymotrypsin 
family of serine proteases, which have been shown to have a similar action as cysteine proteases, 
have three conserved disulfide bonds. While mutating some of the residues forming disulfide 
bonds to eliminate these bonds has shown no effect on the activity and specificity of 
chymotrypsin,39 mutations to other residues also forming disulfide bonds has shown to negatively 
affect chymotrypsin’s ability to cleave.40  
Additionally, various other types of proteases have been shown to lose catalytic activity 
when cysteines involved in a disulfide bond are mutated. The aspartic acid protease plasmepsin V 
has two disulfide linkages in its active fold,41 and the metalloprotease PST-01 secreted by 
Pseudomonas aeruginosa also has two disulfide bonds. One of these bonds plays an essential role 
in its catalytic activity, while the other plays an important role in its stability.42 Foot-and-Mouth 
Disease Virus (FMDV) is also of the order Picornavirales and utilizes a 3C protease. Mutation of 
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one of the cysteine residues that is not an identified catalytic residue drastically reduces its 
proteolytic activity. This decrease in activity is believed to be due to the residue forming 
intermolecular disulfide bonds.43 Because mutating C2773 demonstrates an abolition of catalytic 
activity by the MCDV-S protease, it is likely that it participates in some kind of disulfide linkage 
that is crucial to the structural fold of the catalytic center of the protease.  
A second possible mechanism is that this mutation is interrupting a role the neighboring 
tyrosine may be playing. The amino acid adjacent to C2773 that was also mutated when inserting 
an NheI site for mutant 5 is Y2774. Tyrosine residues have been shown to play a role in 3C-like 
proteases by donating a hydrogen bond from its hydroxyl to a histidine catalytic residue. This 
action allows for the catalytic center to be more selective and reject the binding of certain residues 
by keeping the histidine uncharged over a wide range of pHs.44 However, since this residue 
typically just plays a role in regulating specificity, mutating it likely would not abolish catalytic 
activity altogether, making the disulfide bond prediction the more likely explanation. 
Overall, MCDV-S seems to reflect the catalytic residues identified for other waikaviruses, 
and D2704 and C2798 have been confirmed as catalytic residues. While it does not seem that a 
second histidine residue is playing a role, a second cysteine, C2773, seems to be involved in the 
catalytic activity of the protease, although the mechanism of how this residue is acting is unknown.  
Future directions should include more attempts at cloning mutant 2, which targets H2667, 
so that its activity can be explored. This would be beneficial, as this residue is a catalytic residue 
in RTSV-A and hypothesized to be one in MCDV-Tn, so therefore likely completes the catalytic 
triad of MCDV-S. Additional future directions should utilize the anti-protease antibody produced 
by GenScript to determine autocatalytic cleavage sites. It is likely that this antibody will allow for 
the production of a better assay for analysis of the self-cleavage of the protease, since it will not 
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be relying on the detection of Xpress and c-Myc tags, which was shown to be inefficient in this 
experiment. The production of the protease was completed upon the conclusion of this project, and 
therefore will be available for future research (refer to Appendix C and Appendix D for more 
information regarding the protease antibody). Finally, the role of C2773 in cleavage should be 
explored further. One possible experiment could involve treating the protease with 2-
mercaptoethanol, which would break all the disulfide bonds allowing us to determine if this linkage 
is a contributing factor to the protease’s catalytic action. Additionally, cross-linking protein 
analysis could be done to see if there is a disulfide reaction between the protease and its target 
substrate that is necessary for cleavage. 
 
 
CONCLUSIONS 
 We have provided evidence for D2704, C2773, and C2798 playing a role in the catalytic 
activity of the protease of Maize chlorotic dwarf virus. Specifically, it seems that D2704 and 
C2798 are catalytic residues, while C2773 plays a different role that is yet to be determined. 
Additionally, we have rejected the role of H2817 in the catalytic center despite its conservation 
across all waikaviruses and catalytic role in RTSV-A. Furthermore, we have identified the Q5â 
Site-Directed Mutagenesis protocol as one that will successfully implement desired mutations in 
the MCDV protease region, and those mutants are able to be transformed into bacteria. 
Autocatalytic cleavage sites are still to be determined, as an assay to properly demonstrate that 
cleavage still needs to be developed.  
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APPENDIX A 
 
Mutagenesis Multiple Sequence Alignment 
 
Sequencing data of mutants provided by Elim Biopharm. The highlighted bases are those that 
indicate a successful mutation to incorporate an NheI restriction enzyme site at the desired 
location.  
 
 
                      1                                                   50 
                 SPP  .......... .......... .......... .......... .......... 
                Mut1  ..GCTCCGGC CGCCATGGCG GCCGCGGGAA TTCGATTTGT GCAAAACAGA 
                Mut4  ..GCTCCGGC CGCCATGGCG GCCGCGGGAA TTCGATTTGT GCAAAACAGA 
                Mut7  ATGCTCCGGC CGCCATGGCG GCCGCGGGAA TTCGATTTGT GCAAAACAGA 
                Mut5  ........GC CGCCATGGCG GCCGCGGGAA TTCGATTTGT GCAAAACAGA 
                Mut8  .........C CGCCATGGCG GCCGCGGGAA TTCGATTTGT GCAAAACAGA 
                Mut3  .......... .....TGGCG GCCGCGGGAA TTCGATTTGT GCAAAACAGA 
                Mut2  .......... .....TGGCG GCCGCGGGAA TTCGATTTGT GCAAAACAGA 
                Mut6  ........GC CGCCATGGCG GCCGCGGGAA TTCGATTTGT GCAAAACAGA 
           Consensus  .......... .....tggcg gccgcgggaa ttcgatttgt gcaaaacaga 
 
                      51                                                 100 
                 SPP  .......... .......... .......TCC AAACCAGCAA GGAGGCAACA 
                Mut1  CACCATTCGT ACGACGATGA CGATAAGTCC AAACCAGCAA GGAGGCAACA 
                Mut4  CACCATTCGT ACGACGATGA CGATAAGTCC AAACCAGCAA GGAGGCAACA 
                Mut7  CACCATTCGT ACGACGATGA CGATAAGTCC AAACCAGCAA GGAGGCAACA 
                Mut5  CACCATTCGT ACGACGATGA CGATAAGTCC AAACCAGCAA GGAGGCAACA 
                Mut8  CACCATTCGT ACGACGATGA CGATAAGTCC AAACCAGCAA GGAGGCAACA 
                Mut3  CACCATTCGT ACGACGATGA CGATAAGTCC AAACCAGCAA GGAGGCAACA 
                Mut2  CACCATTCGT ACGACGATGA CGATAAGTCC AAACCAGCAA GGAGGCAACA 
                Mut6  CACCATTCGT ACGACGATGA CGATAAGTCC AAACCAGCAA GGAGGCAACA 
           Consensus  caccattcgt acgacgatga cgataagTCC AAACCAGCAA GGAGGCAACA 
 
                      101                                                150 
                 SPP  TGAATTTGAT CTAATGTTCG ATAATCTACC CACTCCACAA GTTGAAGAGC 
                Mut1  TGAATTTGAT CTAATGTTCG ATAATCTACC CACTCCACAA GTTGAAGAGC 
                Mut4  TGAATTTGAT CTAATGTTCG ATAATCTACC CACTCCACAA GTTGAAGAGC 
                Mut7  TGAATTTGAT CTAATGTTCG ATAATCTACC CACTCCACAA GTTGAAGAGC 
                Mut5  TGAATTTGAT CTAATGTTCG ATAATCTACC CACTCCACAA GTTGAAGAGC 
                Mut8  TGAATTTGAT CTAATGTTCG ATAATCTACC CACTCCACAA GTTGAAGAGC 
                Mut3  TGAATTTGAT CTAATGTTCG ATAATCTACC CACTCCACAA GTTGAAGAGC 
                Mut2  TGAATTTGAT CTAATGTTCG ATAATCTACC CACTCCACAA GTTGAAGAGC 
                Mut6  TGAATTTGAT CTAATGTTCG ATAATCTACC CACTCCACAA GTTGAAGAGC 
           Consensus  TGAATTTGAT CTAATGTTCG ATAATCTACC CACTCCACAA GTTGAAGAGC 
 
                      151                                                200 
                 SPP  TAAAGAGTGA GATGACCTGC GCCAGTGCCA GTGATGAGCA TAAGACTCAG 
                Mut1  TAAAGAGTGA GATGACCTGC GCCAGTGCCA GTGATGAGCA TAAGACTCAG 
                Mut4  TAAAGAGTGA GATGACCTGC GCCAGTGCCA GTGATGAGCA TAAGACTCAG 
                Mut7  TAAAGAGTGA GATGACCTGC GCCAGTGCCA GTGATGAGCA TAAGACTCAG 
                Mut5  TAAAGAGTGA GATGACCTGC GCCAGTGCCA GTGATGAGCA TAAGACTCAG 
                Mut8  TAAAGAGTGA GATGACCTGC GCCAGTGCCA GTGATGAGCA TAAGACTCAG 
                Mut3  TAAAGAGTGA GATGACCTGC GCCAGTGCCA GTGATGAGCA TAAGACTCAG 
                Mut2  TAAAGAGTGA GATGACCTGC GCCAGTGCCA GTGATGAGCA TAAGACTCAG 
                Mut6  TAAAGAGTGA GATGACCTGC GCCAGTGCCA GTGATGAGCA TAAGACTCAG 
           Consensus  TAAAGAGTGA GATGACCTGC GCCAGTGCCA GTGATGAGCA TAAGACTCAG 
 
                      201                                                250 
                 SPP  TATGTTAAAA GAAGAGTGGG ACCTGTAAGC AAACGTAAGG ATGCTTCGGT 
                Mut1  TATGTTAAAA GAAGAGTGSG ACCTGTAAGC AAACGTAAGG ATGCTTCGGT 
                Mut4  TATGTTAAAA GAAGAGTGSG ACCTGTAAGC AAACGTAAGG ATGCTTCGGT 
                Mut7  TATGTTAAAA GAAGAGTGSG ACCTGTAAGC AAACGTAAGG ATGCTTCGGT 
                Mut5  TATGTTAAAA GAAGAGTGSG ACCTGTAAGC AAACGTAAGG ATGCTTCGGT 
                Mut8  TATGTTAAAA GAAGAGTGSG ACCTGTAAGC AAACGTAAGG ATGCTTCGGT 
                Mut3  TATGTTAAAA GAAGAGTGSG ACCTGTAAGC AAACGTAAGG ATGCTTCGGT 
                Mut2  TATGTTAAAA GAAGAGTGSG ACCTGTAAGC AAACGTAAGG ATGCTTCGGT 
                Mut6  TATGTTAAAA GAAGAGTGSG ACCTGTAAGC AAACGTAAGG ATGCTTCGGT 
           Consensus  TATGTTAAAA GAAGAGTGsG ACCTGTAAGC AAACGTAAGG ATGCTTCGGT 
 
                      251                                                300 
                 SPP  AGCAGAAATT AGTGGAGCTC ATGCGAGTGA TCAGCATCAC ACAGAATACT 
                Mut1  AGCAGAAATT AGTGGAGCTC ATGCGAGTGA TCAGCATCAC ACAGAATACT 
                Mut4  AGCAGAAATT AGTGGAGCTC ATGCGAGTGA TCAGCATCAC ACAGAATACT 
                Mut7  AGCAGAAATT AGTGGAGCTC ATGCGAGTGA TCAGCATCAC ACAGAATACT 
                Mut5  AGCAGAAATT AGTGGAGCTC ATGCGAGTGA TCAGCATCAC ACAGAATACT 
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                Mut8  AGCAGAAATT AGTGGAGCTC ATGCGAGTGA TCAGCATCAC ACAGAATACT 
                Mut3  AGCAGAAATT AGTGGAGCTC ATGCGAGTGA TCAGCATCAC ACAGAATACT 
                Mut2  AGCAGAAATT AGTGGAGCTC ATGCGAGTGA TCAGCATCAC ACAGAATACT 
                Mut6  AGCAGAAATT AGTGGAGCTC ATGCGAGTGA TCAGCATCAC ACAGAATACT 
           Consensus  AGCAGAAATT AGTGGAGCTC ATGCGAGTGA TCAGCATCAC ACAGAATACT 
 
                      301                                                350 
                 SPP  TGAAAGCACG CGTTCCACTC ATGAAAAGAA TAGCTACCAA AGAGAGCTAT 
                Mut1  TGAAAGCACG CGTTCCACTC ATGAAAAGAA TAGCTACCAA AGAGAGCTAT 
                Mut4  TGAAAGCACG CGTTCCACTC ATGAAAAGAA TAGCTACCAA AGAGAGCTAT 
                Mut7  TGAAAGCACG CGTTCCACTC ATGAAAAGAA TAGCTACCAA AGAGAGCTAT 
                Mut5  TGAAAGCACG CGTTCCACTC ATGAAAAGAA TAGCTACCAA AGAGAGCTAT 
                Mut8  TGAAAGCACG CGTTCCACTC ATGAAAAGAA TAGCTACCAA AGAGAGCTAT 
                Mut3  TGAAAGCACG CGTTCCACTC ATGAAAAGAA TAGCTACCAA AGAGAGCTAT 
                Mut2  TGAAAGCACG CGTTCCACTC ATGAAAAGAA TAGCTACCAA AGAGAGCTAT 
                Mut6  TGAAAGCACG CGTTCCACTC ATGAAAAGAA TAGCTACCAA AGAGAGCTAT 
           Consensus  TGAAAGCACG CGTTCCACTC ATGAAAAGAA TAGCTACCAA AGAGAGCTAT 
 
                      351                                                400 
                 SPP  GTTGTAACTT ACGATGACGA ACCCAGCTCT CATATTTCCC TAGCTCGCAG 
                Mut1  GTTGTAACTT ACGATGACGA ACCCAGCTCT CATATTTCCC TAGCTCGCAG 
                Mut4  GTTGTAACTT ACGATGACGA ACCCAGCTCT CATATTTCCC TAGCTCGCAG 
                Mut7  GTTGTAACTT ACGATGACGA ACCCAGCTCT CATATTTCCC TAGCTCGCAG 
                Mut5  GTTGTAACTT ACGATGACGA ACCCAGCTCT CATATTTCCC TAGCTCGCAG 
                Mut8  GTTGTAACTT ACGATGACGA ACCCAGCTCT CATATTTCCC TAGCTCGCAG 
                Mut3  GTTGTAACTT ACGATGACGA ACCCAGCTCT CATATTTCCC TAGCTCGCAG 
                Mut2  GTTGTAACTT ACGATGACGA ACCCAGCTCT CATATTTCCC TAGCTCGCAG 
                Mut6  GTTGTAACTT ACGATGACGA ACCCAGCTCT CATATTTCCC TAGCTCGCAG 
           Consensus  GTTGTAACTT ACGATGACGA ACCCAGCTCT CATATTTCCC TAGCTCGCAG 
 
                      401                                                450 
                 SPP  GATCCGACGT ACACGACTGG CAAGAGCCAT CAAGCAAATG GCAGTCCTGG 
                Mut1  GATCCGACGT ACACGACTGG CAAGAGCCAT CAAGCAAATG GCAGTCCTGG 
                Mut4  GATCCGACGT ACACGACTGG CAAGAGCCAT CAAGCAAATG GCAGTCCTGG 
                Mut7  GATCCGACGT ACACGACTGG CAAGAGCCAT CAAGCAAATG GCAGTCCTGG 
                Mut5  GATCCGACGT ACACGACTGG CAAGAGCCAT CAAGCAAATG GCAGTCCTGG 
                Mut8  GATCCGACGT ACACGACTGG CAAGAGCCAT CAAGCAAATG GCAGTCCTGG 
                Mut3  GATCCGACGT ACACGACTGG CAAGAGCCAT CAAGCAAATG GCAGTCCTGG 
                Mut2  GATCCGACGT ACACGACTGG CAAGAGCCAT CAAGCAAATG GCAGTCCTGG 
                Mut6  GATCCGACGT ACACGACTGG CAAGAGCCAT CAAGCAAATG GCAGTCCTGG 
           Consensus  GATCCGACGT ACACGACTGG CAAGAGCCAT CAAGCAAATG GCAGTCCTGG 
 
                      451                                                500 
                 SPP  AGGACTTCCC ATCTACCTTG GAAGAGATAC GACTTTGGAG ACAAAACGCT 
                Mut1  AGGACTTCCC ATCTACCTTG GAAGAGATAC GACTTTGGGC TAGCAACGCT 
                Mut4  AGGACTTCCC ATCTACCTTG GAAGAGATAC GACTTTGGAG ACAAAACGCT 
                Mut7  AGGACTTCCC ATCTACCTTG GAAGAGATAC GACTTTGGAG ACAAAACGCT 
                Mut5  AGGACTTCCC ATCTACCTTG GAAGAGATAC GACTTTGGAG ACAAAACGCT 
                Mut8  AGGACTTCCC ATCTACCTTG GAAGAGATAC GACTTTGGAG ACAAAACGCT 
                Mut3  AGGACTTCCC ATCTACCTTG GAAGAGATAC GACTTTGGAG ACAAAACGCT 
                Mut2  AGGACTTCCC ATCTACCTTG GAAGAGATAC GACTTTGGAG ACAAAACGCT 
                Mut6  AGGACTTCCC ATCTACCTTG GAAGAGATAC GACTTTGGAG ACAAAACGCT 
           Consensus  AGGACTTCCC ATCTACCTTG GAAGAGATAC GACTTTGGAG ACAAAACGCT 
 
                      501                                                550 
                 SPP  GCAAATAAAG GGGTTATTGT TCCGAAGTAC TCAACAAGTG GGAAATTCTT 
                Mut1  GCAAATAAAG GGGTTATTGT TCCGAAGTAC TCAACAAGWG GGAAATTCTT 
                Mut4  GCAAATAAAG GGGTTATTGT TCCGAAGTAC TCAACAAGWG GGAAATTCTT 
                Mut7  GCAAATAAAG GGGTTATTGT TCCGAAGTAC TCAACAAGWG GGAAATTCTT 
                Mut5  GCAAATAAAG GGGTTATTGT TCCGAAGTAC TCAACAAGWG GGAAATTCTT 
                Mut8  GCAAATAAAG GGGTTATTGT TCCGAAGTAC TCAACAAGWG GGAAATTCTT 
                Mut3  GCAAATAAAG GGGTTATTGT TCCGAAGTAC TCAACAAGWG GGAAATTCTT 
                Mut2  GCAAATAAAG GGGTTATTGT TCCGAAGTAC TCAACAAGWG GGAAATTCTT 
                Mut6  GCAAATAAAG GGGTTATTGT TCCGAAGTAC TCAACAAGWG GGAAATTCTT 
           Consensus  GCAAATAAAG GGGTTATTGT TCCGAAGTAC TCAACAAGwG GGAAATTCTT 
 
                      551                                                600 
                 SPP  CAGTGGCTTG TTGGATGATG AAGAAGAAGA ACCTCAGAAC GTGAATATGT 
                Mut1  CAGTGGCTTG TTGGATGATG AAGAAGAAGA ACCTCAGAAC GTGAATATGT 
                Mut4  CAGTGGCTTG TTGGATGATG AAGAAGAAGA ACCTCAGAAC GTGAATATGT 
                Mut7  CAGTGGCTTG TTGGATGATG AAGAAGAAGA ACCTCAGAAC GTGAATATGT 
                Mut5  CAGTGGCTTG TTGGATGATG AAGAAGAAGA ACCTCAGAAC GTGAATATGT 
                Mut8  CAGTGGCTTG TTGGATGATG AAGAAGAAGA ACCTCAGAAC GTGAATATGT 
                Mut3  CAGTGGCTTG TTGGATGATG AAGAAGAAGA ACCTCAGAAC GTGAATATGT 
                Mut2  CAGTGGCTTG TTGGATGATG AAGAAGAAGA ACCTCAGAAC GTGAATATGT 
                Mut6  CAGTGGCTTG TTGGATGATG AAGAAGAAGA ACCTCAGAAC GTGAATATGT 
           Consensus  CAGTGGCTTG TTGGATGATG AAGAAGAAGA ACCTCAGAAC GTGAATATGT 
 
                      601                                                650 
                 SPP  TGAACGAAGA GGACATTGAG GTAGATAAGC GAATGTTTGA GAAGATTTCT 
                Mut1  TGAACGAAGA GGACATTGAG GTAGATAAGC GAATGTTTGA GAAGATTTCT 
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                Mut4  TGAACGAAGA GGACATTGAG GTAGATAAGC GAATGTTTGA GAAGATTTCT 
                Mut7  TGAACGAAGA GGACATTGAG GTAGATAAGC GAATGTTTGA GAAGATTTCT 
                Mut5  TGAACGAAGA GGACATTGAG GTAGATAAGC GAATGTTTGA GAAGATTTCT 
                Mut8  TGAACGAAGA GGACATTGAG GTAGATAAGC GAATGTTTGA GAAGATTTCT 
                Mut3  TGAACGAAGA GGACATTGAG GTAGATAAGC GAATGTTTGA GAAGATTTCT 
                Mut2  TGAACGAAGA GGACATTGAG GTAGATAAGC GAATGTTTGA GAAGATTTCT 
                Mut6  TGAACGAAGA GGACATTGAG GTAGATAAGC GAATGTTTGA GAAGATTTCT 
           Consensus  TGAACGAAGA GGACATTGAG GTAGATAAGC GAATGTTTGA GAAGATTTCT 
 
                      651                                                700 
                 SPP  GAAGTTATAA GCGTGATTCA ACCCAGAAAG AATGAGCTGG AAAGAATGAT 
                Mut1  GAAGTTATAA GCGTGATTCA ACCCAGAAAG AATGAGCTGG AAAGAATGAT 
                Mut4  GAAGTTATAA GCGTGATTCA ACCCAGAAAG AATGAGCTGG AAAGAATGAT 
                Mut7  GAAGTTATAA GCGTGATTCA ACCCAGAAAG AATGAGCTGG AAAGAATGAT 
                Mut5  GAAGTTATAA GCGTGATTCA ACCCAGAAAG AATGAGCTGG AAAGAATGAT 
                Mut8  GAAGTTATAA GCGTGATTCA ACCCAGAAAG AATGAGCTGG AAAGAATGAT 
                Mut3  GAAGTTATAA GCGTGATTCA ACCCAGAAAG AATGAGCTGG AAAGAATGAT 
                Mut2  GAAGTTATAA GCGTGATTCA ACCCAGAAAG AATGAGCTGG AAAGAATGAT 
                Mut6  GAAGTTATAA GCGTGATTCA ACCCAGAAAG AATGAGCTGG AAAGAATGAT 
           Consensus  GAAGTTATAA GCGTGATTCA ACCCAGAAAG AATGAGCTGG AAAGAATGAT 
 
                      701                                                750 
                 SPP  TGAGGAAGGC GTACACCACA AGGTCGTAAA GCAGGCAAGG GTTAACGACA 
                Mut1  TGAGGAAGGC GTACACCACA AGGTCGTAAA GCAGGCAAGG GTTAACGACA 
                Mut4  TGAGGAAGGC GTACACCACA AGGTCGTAAA GCAGGCAAGG GTTAACGACA 
                Mut7  TGAGGAAGGC GTACACCACA AGGTCGTAAA GCAGGCAAGG GTTAACGACA 
                Mut5  TGAGGAAGGC GTACACCACA AGGTCGTAAA GCAGGCAAGG GTTAACGACA 
                Mut8  TGAGGAAGGC GTACACCACA AGGTCGTAAA GCAGGCAAGG GTTAACGACA 
                Mut3  TGAGGAAGGC GTACACCACA AGGTCGTAAA GCAGGCAAGG GTTAACGACA 
                Mut2  TGAGGAAGGC GTACACCACA AGGTCGTAAA GCAGGCAAGG GTTAACGACA 
                Mut6  TGAGGAAGGC GTACACCACA AGGTCGTAAA GCAGGCAAGG GTTAACGACA 
           Consensus  TGAGGAAGGC GTACACCACA AGGTCGTAAA GCAGGCAAGG GTTAACGACA 
 
                      751                                                800 
                 SPP  AGGGCTTAGC CAAAGACCCC AACATGGTGA CTATCTTGAC GGACAAATTA 
                Mut1  AGGGCTTAGC CAAAGACCCC AACATGGTGA CTATCTTGAC GGACAAATTA 
                Mut4  AGGGCTTAGC CAAAGACCCC AACATGGTGA CTATCTTGAC GGACAAATTA 
                Mut7  AGGGCTTAGC CAAAGACCCC AACATGGTGA CTATCTTGAC GGACAAATTA 
                Mut5  AGGGCTTAGC CAAAGACCCC AACATGGTGA CTATCTTGAC GGACAAATTA 
                Mut8  AGGGCTTAGC CAAAGACCCC AACATGGTGA CTATCTTGAC GGACAAATTA 
                Mut3  AGGGCTTAGC CAAAGACCCC AACATGGTGA CTATCTTGAC GGACAAATTA 
                Mut2  AGGGCTTAGC CAAAGACCCC AACATGGTGA CTATCTTGAC GGACAAATTA 
                Mut6  AGGGCTTAGC CAAAGACCCC AACATGGTGA CTATCTTGAC GGACAAATTA 
           Consensus  AGGGCTTAGC CAAAGACCCC AACATGGTGA CTATCTTGAC GGACAAATTA 
 
                      801                                                850 
                 SPP  ATTAATATTA GTGCGGTGAT CGTCAATTTA ACGCCGACAC GCCGGGCATA 
                Mut1  ATTAATATTA GTGCGGTGAT CGTCAATTTA ACGCCGACAC GCCGGGCATA 
                Mut4  ATTAATATTA GTGCGGTGAT CGTCAATTTA ACGCCGACAC GCCGGGCATA 
                Mut7  ATTAATATTA GTGCGGTGAT CGTCAATTTA ACGCCGACAC GCCGGGCATA 
                Mut5  ATTAATATTA GTGCGGTGAT CGTCAATTTA ACGCCGACAC GCCGGGCATA 
                Mut8  ATTAATATTA GTGCGGTGAT CGTCAATTTA ACGCCGACAC GCCGGGCATA 
                Mut3  ATTAATATTA GTGCGGTGAT CGTCAATTTA ACGCCGACAC GCCGGGCATA 
                Mut2  ATTAATATTA GTGCGGTGAT CGTCAATTTA ACGCCGACAC GCCGGGCATA 
                Mut6  ATTAATATTA GTGCGGTGAT CGTCAATTTA ACGCCGACAC GCCGGGCATA 
           Consensus  ATTAATATTA GTGCGGTGAT CGTCAATTTA ACGCCGACAC GCCGGGCATA 
 
                      851                                                900 
                 SPP  CATGAACGTG GTACGTCTTA TAGGCACTAT AGTTGTTTGC CCAGCCCACT 
                Mut1  CATGAACGTG GTACGTCTTA TAGGCACTAT AGTTGTTTGC CCAGCCCACT 
                Mut4  CATGAACGTG GTACGTCTTA TAGGCACTAT AGTTGTTTGC CCAGCCCACT 
                Mut7  CATGAACGTG GTACGTCTTA TAGGCACTAT AGTTGTTTGC CCAGCCCACT 
                Mut5  CATGAACGTG GTACGTCTTA TAGGCACTAT AGTTGTTTGC CCAGCCCACT 
                Mut8  CATGAACGTG GTACGTCTTA TAGGCACTAT AGTTGTTTGC CCAGCCCACT 
                Mut3  CATGAACGTG GTACGTCTTA TAGGCACTAT AGTTGTTTGC CCAGCCCACT 
                Mut2  CATGAACGTG GTACGTCTTA TAGGCACTAT AGTTGTTTGC CCAGCCGCTA 
                Mut6  CATGAACGTG GTACGTCTTA TAGGCACTAT AGTTGTTTGC CCAGCCCACT 
           Consensus  CATGAACGTG GTACGTCTTA TAGGCACTAT AGTTGTTTGC CCAGCCcact 
 
                      901                                                950 
                 SPP  ACTTGGAAGC TTTAGAGGAA GGAGATGAGC TGTATTTCAT TTGCTTCTCA 
                Mut1  ACTTGGAAGC TTTAGAGGAA GGAGATGAGC TGTATTTCAT TTGCTTCTCA 
                Mut4  ACTTGGAAGC TTTAGAGGAA GGAGATGAGC TGTATTTCAT TTGCTTCTCA 
                Mut7  ACTTGGAAGC TTTAGAGGAA GGAGATGAGC TGTATTTCAT TTGCTTCTCA 
                Mut5  ACTTGGAAGC TTTAGAGGAA GGAGATGAGC TGTATTTCAT TTGCTTCTCA 
                Mut8  ACTTGGAAGC TTTAGAGGAA GGAGATGAGC TGTATTTCAT TTGCTTCTCA 
                Mut3  ACTTGGAAGC TTTAGAGGAA GGAGATGAGC TGTATTTCAT TTGCTTCTCA 
                Mut2  GCTTGGAAGC TTTAGAGGAA GGAGATGAGC TGTATTTCAT TTGCTTCTCA 
                Mut6  ACTTGGAAGC TTTAGAGGAA GGAGATGAGC TGTATTTCAT TTGCTTCTCA 
           Consensus  aCTTGGAAGC TTTAGAGGAA GGAGATGAGC TGTATTTCAT TTGCTTCTCA 
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                      951                                               1000 
                 SPP  TTGGTTATCA AGCTCACTTT TGATCCAAGT AGAGTGACTC TCGTGAATAG 
                Mut1  TTGGTTATCA AGCTCACTTT TGATCCAAGT AGAGTGACTC TCGTGAATAG 
                Mut4  TTGGTTATCA AGCTCACTTT TGATCCAAGT AGAGTGACTC TCGTGAATAG 
                Mut7  TTGGTTATCA AGCTCACTTT TGATCCAAGT AGAGTGACTC TCGTGAATAG 
                Mut5  TTGGTTATCA AGCTCACTTT TGATCCAAGT AGAGTGACTC TCGTGAATAG 
                Mut8  TTGGTTATCA AGCTCACTTT TGATCCAAGT AGAGTGACTC TCGTGAATAG 
                Mut3  TTGGTTATCA AGCTCACTTT TGCTAGCAGT AGAGTGACTC TCGTGAATAG 
                Mut2  TTGGTTATCA AGCTCACTTT TGATCCAAGT AGAGTGACTC TCGTGAATAG 
                Mut6  TTGGTTATCA AGCTCACTTT TGATCCAAGT AGAGTGACTC TCGTGAATAG 
           Consensus  TTGGTTATCA AGCTCACTTT TGATCCAAGT AGAGTGACTC TCGTGAATAG 
 
                      1001                                              1050 
                 SPP  CCAGCAGGAT TTGATGGTTT GGGATCTTGG GAACATGGTA CCACCCTCAA 
                Mut1  CCAGCAGGAT TTGATGGTTT GGGATCTTGG GAACATGGTA CCACCCTCAA 
                Mut4  CCAGGCTAGC TTGATGGTTT GGGATCTTGG GAACATGGTA CCACCCTCAA 
                Mut7  CCAGCAGGAT TTGATGGTTT GGGATCTTGG GAACATGGTA CCACCCTCAA 
                Mut5  CCAGCAGGAT TTGATGGTTT GGGATCTTGG GAACATGGTA CCACCCTCAA 
                Mut8  CCAGCAGGAT TTGATGGTTT GGGATCTTGG GAACATGGTA CCACCCTCAA 
                Mut3  CCAGCAGGAT TTGATGGTTT GGGATCTTGG GAACATGGTA CCACCCTCAA 
                Mut2  CCAGCAGGAT TTGATGGTTT GGGATCTTGG GAACATGGTA CCACCCTCAA 
                Mut6  CCAGCAGGAT TTGATGGTTT GGGATCTTGG GAACATGGTA CCACCCTCAA 
           Consensus  CCAGCAGGAT TTGATGGTTT GGGATCTTGG GAACATGGTA CCACCCTCAA 
 
                      1051                                              1100 
                 SPP  TTGATACTCT TAAAATGATA CCCACGCTTG AAGACTGGGA TCACTTTCAG 
                Mut1  TTGATACTCT TAAAATGATA CCCACGCTTG AAGACTGGGA TCACTTTCAG 
                Mut4  TTGATACTCT TAAAATGATA CCCACGCTTG AAGACTGGGA TCACTTTCAG 
                Mut7  TTGATACTCT TAAAATGATA CCCACGCTTG AAGACTGGGA TCACTTTCAG 
                Mut5  TTGATACTCT TAAAATGATA CCCACGCTTG AAGACTGGGA TCACTTTCAG 
                Mut8  TTGATACTCT TAAAATGATA CCCACGCTTG AAGACTGGGA TCACTTTCAG 
                Mut3  TTGATACTCT TAAAATGATA CCCACGCTTG AAGACTGGGA TCACTTTCAG 
                Mut2  TTGATACTCT TAAAATGATA CCCACGCTTG AAGACTGGGA TCACTTTCAG 
                Mut6  TTGATACTCT TAAAATGATA CCCACGCTTG AAGACTGGGA TCACTTTCAG 
           Consensus  TTGATACTCT TAAAATGATA CCCACGCTTG AAGACTGGGA TCACTTTCAG 
 
                      1101                                              1150 
                 SPP  GATGGACCAG GAGCCTTTGC TGTTACGAAA TATAACTCGA AATTCCCAAC 
                Mut1  GATGGACCAG GAGCCTTTGC TGTTACGAAA TATAACTCGA AATTCCCAAC 
                Mut4  GATGGACCAG GAGCCTTTGC TGTTACRAAA TATAACTCGA AATTCCCAAC 
                Mut7  GATGGACCAG GAGCCTTTGC TGTTACRAAA TATAACTCGA AATTCCCAAC 
                Mut5  GATGGACCAG GAGCCTTTGC TGTTACRAAA TATAACTCGA AATTCCCAAC 
                Mut8  GATGGACCAG GAGCCTTTGC TGTTACGAAA TATAACTCGA AATTCCCAAC 
                Mut3  GATGGACCAG GAGCCTTTGC TGTTACRAAA TATAACTCGA AATTCCCAAC 
                Mut2  GATGGACCAG GAGCCTTTGC TGTTACRAAA TATAACTCGA AATTCCCAAC 
                Mut6  GATGGACCAG GAGCCTTTGC TGTTACRAAA TATAACTCGA AATTCCCAAC 
           Consensus  GATGGACCAG GAGCCTTTGC TGTTACgAAA TATAACTCGA AATTCCCAAC 
 
                      1151                                              1200 
                 SPP  CAATTATATC AACACACTAA CTATGATTGA GAGGATTAGG GCAAATACTC 
                Mut1  CAATTATATC AACACACTRA CTATGATTGA GAGGATTAGG GCAAATACTC 
                Mut4  CAATTATATY AACACACTRA CTATGATTGA GAGGATTAGG GCAAATACTC 
                Mut7  CAATTATATY AACACACTRA CTATGATTGA GAGGATTAGG GCAAATACTC 
                Mut5  CAATTATATY AACACACTRA CTATGATTGA GAGGATTAGG GCAAATACTC 
                Mut8  CAATTATATC AACACACTAA CTATGATTGA GAGGATTAGG GCAAATACTC 
                Mut3  CAATTATATY AACACACTRA CTATGATTGA GAGGATTAGG GCAAATACTC 
                Mut2  CAATTATATY AACACACTRA CTATGATTGA GAGGATTAGG GCAAATACTC 
                Mut6  CAATTATATY AACACACTRA CTATGATTGA GAGGATTAGG GCAAATACTC 
           Consensus  CAATTATATc AACACACTrA CTATGATTGA GAGGATTAGG GCAAATACTC 
 
                      1201                                              1250 
                 SPP  AGAATCCCAC GGGTTGTTAT TCCATGATGG GCTCCCAACA TACAATCACC 
                Mut1  AGAATCCCAC GGGTTGTTAT TCCATGATGG GCTCCCAACA TACAATCACC 
                Mut4  AGAATCCCAC GGGTTGTTAT TCCATGATGG GCTCCCAACA TACAATCACC 
                Mut7  AGAATCCCAC GGGTTGTTAT TCCATGATGG GCTCCCAACA TACAATCACC 
                Mut5  AGAATCCCAC GGGTGCTAGC TCCATGATGG GCTCCCAACA TACAATCACC 
                Mut8  AGAATCCCAC GGGTTGTTAT TCCATGATGG GCTCCCAACA TACAATCACC 
                Mut3  AGAATCCCAC GGGTTGTTAT TCCATGATGG GCTCCCAACA TACAATCACC 
                Mut2  AGAATCCCAC GGGTTGTTAT TCCATGATGG GCTCCCAACA TACAATCACC 
                Mut6  AGAATCCCAC GGGTTGTTAT TCCATGATGG GCTCCCAACA TACAATCACC 
           Consensus  AGAATCCCAC GGGTTGTTAT TCCATGATGG GCTCCCAACA TACAATCACC 
 
                      1251                                              1300 
                 SPP  ACAGGATTGC GATATCAAAT GTTCTCTCTT GATGGATTCT GCGGTGGGTT 
                Mut1  ACAGGATTGC GATATCAAAT GTTCTCTCTT GATGGATTCT GCGGTGGGTT 
                Mut4  ACAGGATTGC GATATCAAAT GTTCTCTCTT GATGGATTCT GYGGTGGGTT 
                Mut7  ACAGGATTGC GATATCAAAT GTTCTCTCTT GATGGATTCT GYGGTGGGTT 
                Mut5  ACAGGATTGC GATATCAAAT GTTCTCTCTT GATGGATTCT GYGGTGGGTT 
                Mut8  ACAGGATTGC GATATCAAAT GTTCTCTCTT GATGGATTCT GCGGTGGGTT 
                Mut3  ACAGGATTGC GATATCAAAT GTTCTCTCTT GATGGATTCT GYGGTGGGTT 
                Mut2  ACAGGATTGC GATATCAAAT GTTCTCTCTT GATGGATTCT GYGGTGGGTT 
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                Mut6  ACAGGATTGC GATATCAAAT GTTCTCTCTT GATGGATTCG CTAGCGGGTT 
           Consensus  ACAGGATTGC GATATCAAAT GTTCTCTCTT GATGGATTCt gcgGtGGGTT 
 
                      1301                                              1350 
                 SPP  AATCCTGAGA GCCAGCACAA ACATGGTGAG AAAGGTCGTC GGGATCCACG 
                Mut1  AATCCTGAGA GCCAGCACAA ACATGGTGAG AAAGGTCGTC GGGATCCACG 
                Mut4  AATCCTGAGA GCCAGCACAA ACATGGTGAG AAAGGTCGTC GGGATCCACG 
                Mut7  AATCCTGAGA GCCAGCACAA ACATGGTGAG AAAGGTCGTC GGGATCGCTA 
                Mut5  AATCCTGAGA GCCAGCACAA ACATGGTGAG AAAGGTCGTC GGGATCCACG 
                Mut8  AATCCTGAGA GCCAGCACAA ACATGGTGAG AAAGGTCGTC GGGATCCACG 
                Mut3  AATCCTGAGA GCCAGCACAA ACATGGTGAG AAAGGTCGTC GGGATCCACG 
                Mut2  AATCCTGAGA GCCAGCACAA ACATGGTGAG AAAGGTCGTC GGGATCCACG 
                Mut6  AATCCTGAGA GCCAGCACAA ACATGGTGAG AAAGGTCGTC GGGATCCACG 
           Consensus  AATCCTGAGA GCCAGCACAA ACATGGTGAG AAAGGTCGTC GGGATCCACG 
 
                      1351                                              1400 
                 SPP  TTGCTGGAAG CCAGAATCAC GCTATGGGAT ATGCAGAGTG CCTTATTGCC 
                Mut1  TTGCTGGAAG CCAGAATCAC GCTATGGGAT ATGCAGAGTG CCTTATTGCC 
                Mut4  TTGCTGGAAG CCAGAATCAC GCTATGGGAT ATGCAGAGTG CCTTATTGCC 
                Mut7  GCGCTGGAAG CCAGAATCAC GCTATGGGAT ATGCAGAGTG CCTTATTGCC 
                Mut5  TTGCTGGAAG CCAGAATCAC GCTATGGGAT ATGCAGAGTG CCTTATTGCC 
                Mut8  TTGCTGGAAG CCAGAATCAC GCTATGGGAT ATGCAGAGTG CCTTATTGCC 
                Mut3  TTGCTGGAAG CCAGAATCAC GCTATGGGAT ATGCAGAGTG CCTTATTGCC 
                Mut2  TTGCTGGAAG CCAGAATCAC GCTATGGGAT ATGCAGAGTG CCTTATTGCC 
                Mut6  TTGCTGGAAG CCAGAATCAC GCTATGGGAT ATGCAGAGTG CCTTATTGCC 
           Consensus  TTGCTGGAAG CCAGAATCAC GCTATGGGAT ATGCAGAGTG CCTTATTGCC 
 
                      1401                                              1450 
                 SPP  GAAGATCTAC GGGCTGCAGT GGCGAGATTG GCGCTAGATC CTAGAAGCAC 
                Mut1  GAAGATCTAC GGGCTGCAGT GGCGAGATTG GCGCTAGATC CTAGAAGCAC 
                Mut4  GAAGATCTAC GGGCTGCAGT GGCGAGATTG GCGCTAGATC CTAGAAGCAC 
                Mut7  GAAGATCTAC GGGCTGCAGT GGCGAGATTG GCGCTAGATC CTAGAAGCAC 
                Mut5  GAAGATCTAC GGGCTGCAGT GGCGAGATTG GCGCTAGATC CTAGAAGCAC 
                Mut8  GAAGATCTAC GGGCTAGCGT GGCGAGATTG GCGCTAGATC CTAGAAGCAC 
                Mut3  GAAGATCTAC GGGCTGCAGT GGCGAGATTG GCGCTAGATC CTAGAAGCAC 
                Mut2  GAAGATCTAC GGGCTGCAGT GGCGAGATTG GCGCTAGATC CTAGAAGCAC 
                Mut6  GAAGATCTAC GGGCTGCAGT GGCGAGATTG GCGCTAGATC CTAGAAGCAC 
           Consensus  GAAGATCTAC GGGCTGCAGT GGCGAGATTG GCGCTAGATC CTAGAAGCAC 
 
                      1451                                              1500 
                 SPP  CATCCAGGCA AGTCTGAAAG GTAGGATTGA TGCTGTTTCT AAACAATGTG 
                Mut1  CATCCAGGCA AGTCTGAAAG GTAGGATTGA TGCTGTTTCT AAACAATGTG 
                Mut4  CATCCAGGCA AGTCTGAAAG GTAGGATTGA TGCTGTTTCT AAACAATGTG 
                Mut7  CATCCAGGCA AGTCTGAAAG GTAGGATTGA TGCTGTTTCT AAACAATGTG 
                Mut5  CATCCAGGCA AGTCTGAAAG GTAGGATTGA TGCTGTTTCT AAACAATGTG 
                Mut8  CATCCAGGCA AGTCTGAAAG GTAGGATTGA TGCTGTTTCT AAACAATGTG 
                Mut3  CATCCAGGCA AGTCTGAAAG GTAGGATTGA TGCTGTTTCT AAACAATGTG 
                Mut2  CATCCAGGCA AGTCTGAAAG GTAGGATTGA TGCTGTTTCT AAACAATGTG 
                Mut6  CATCCAGGCA AGTCTGAAAG GTAGGATTGA TGCTGTTTCT AAACAATGTG 
           Consensus  CATCCAGGCA AGTCTGAAAG GTAGGATTGA TGCTGTTTCT AAACAATGTG 
 
                      1501                                              1550 
                 SPP  GTTTAGACAG AGCTCTGGGT ACGATAGGAT GTCACGGGAA AGTTGCCTCT 
                Mut1  GTTTAGACAG AGCTCTGGGT ACGATAGGAT GTCACGGGAA AGTTGCCTCT 
                Mut4  GTTTAGACAG AGCTCTGGGT ACGATAGGAT GTCACGGGAA AGTTGCCTCT 
                Mut7  GTTTAGACAG AGCTCTGGGT ACGATAGGAT GTCACGGGAA AGTTGCCTCT 
                Mut5  GTTTAGACAG AGCTCTGGGT ACGATAGGAT GTCACGGGAA AGTTGCCTCT 
                Mut8  GTTTAGACAG AGCTCTGGGT ACGATAGGAT GTCACGGGAA AGTTGCCTCT 
                Mut3  GTTTAGACAG AGCTCTGGGT ACGATAGGAT GTCACGGGAA AGTTGCCTCT 
                Mut2  GTTTAGACAG AGCTCTGGGT ACGATAGGAT GTCACGGGAA AGTTGCCTCT 
                Mut6  GTTTAGACAG AGCTCTGGGT ACGATAGGAT GTCACGGGAA AGTTGCCTCT 
           Consensus  GTTTAGACAG AGCTCTGGGT ACGATAGGAT GTCACGGGAA AGTTGCCTCT 
 
                      1551                                              1600 
                 SPP  GAAGATATTA CAAGTGCCGC CACGAAGACT TCCATAAGAA AGTCAAGAAT 
                Mut1  GAAGATATTA CAAGTGCCGC CACGAAGACT TCCATAAGAA AGTCAAGAAT 
                Mut4  GAAGATATTA CAAGTGCCGC CACGAAGACT TCCATAAGAA AGTCAAGAAT 
                Mut7  GAAGATATTA CAAGTGCCGC CACGAAGACT TCCATAAGAA AGTCAAGAAT 
                Mut5  GAAGATATTA CAAGTGCCGC CACGAAGACT TCCATAAGAA AGTCAAGAAT 
                Mut8  GAAGATATTA CAAGTGCCGC CACGAAGACT TCCATAAGAA AGTCAAGAAT 
                Mut3  GAAGATATTA CAAGTGCCGC CACGAAGACT TCCATAAGAA AGTCAAGAAT 
                Mut2  GAAGATATTA CAAGTGCCGC CACGAAGACT TCCATAAGAA AGTCAAGAAT 
                Mut6  GAAGATATTA CAAGTGCCGC CACGAAGACT TCCATAAGAA AGTCAAGAAT 
           Consensus  GAAGATATTA CAAGTGCCGC CACGAAGACT TCCATAAGAA AGTCAAGAAT 
 
                      1601                                              1650 
                 SPP  ACATGGTCTA GTGGGTGAGA TTAGAACTGA GCCTTCAATT TTACACGCTC 
                Mut1  ACATGGTCTA GTGGGTGAGA TTAGAACTGA GCCTTCAATT TTACACGCTC 
                Mut4  ACATGGTCTA GTGGGTGAGA TTAGAACTGA GCCTTCAATT TTACACGCTC 
                Mut7  ACATGGTCTA GTGGGTGAGA TTAGAACTGA GCCTTCAATT TTACACGCTC 
                Mut5  ACATGGTCTA GTGGGTGAGA TTAGAACTGA GCCTTCAATT TTACACGCTC 
 47 
                Mut8  ACATGGTCTA GTGGGTGAGA TTAGAACTGA GCCTTCAATT TTACACGCTC 
                Mut3  ACATGGTCTA GTGGGTGAGA TTAGAACTGA GCCTTCAATT TTACACGCTC 
                Mut2  ACATGGTCTA GTGGGTGAGA TTAGAACTGA GCCTTCAATT TTACACGCTC 
                Mut6  ACATGGTCTA GTGGGTGAGA TTAGAACTGA GCCTTCAATT TTACACGCTC 
           Consensus  ACATGGTCTA GTGGGTGAGA TTAGAACTGA GCCTTCAATT TTACACGCTC 
 
                      1651                                              1700 
                 SPP  ATGATCCCCG ACTGCCTAAA GACAAG.... .......... .......... 
                Mut1  ATGATCCCCG ACTGCCTAAA GACAAGATTG GGAAATGGGA CCCGGTTATT 
                Mut4  ATGATCCCCG ACTGCCTAAA GACAAGATTG GGAAATGGGA CCCGGTTATT 
                Mut7  ATGATCCCCG ACTGCCTAAA GACAAGATTG GGAAATGGGA CCCGGTTATT 
                Mut5  ATGATCCCCG ACTGCCTAAA GACAAGATTG GGAAATGGGA CCCGGTTATT 
                Mut8  ATGATCCCCG ACTGCCTAAA GACAAGATTG GGAAATGGGA CCCGGTTATT 
                Mut3  ATGATCCCCG ACTGCCTAAA GACAAGATTG GGAAATGGGA CCCGGTTATT 
                Mut2  ATGATCCCCG ACTGCCTAAA GACAAGATTG GGAAATGGGA CCCGGTTATT 
                Mut6  ATGATCCCCG ACTGCCTAAA GACAAGATTG GGAAATGGGA CCCGGTTATT 
           Consensus  ATGATCCCCG ACTGCCTAAA GACAAGattg ggaaatggga cccggttatt 
 
                      1701                                              1750 
                 SPP  .......... .......... .......... .......... .......... 
                Mut1  GAGGCATCAA TGAAGTATGG TTCGAGAATC ACACCGTTCC CTGTAGACCA 
                Mut4  GAGGCATCAA TGAAGTATGG TTCGAGAATC ACACCGTTCC CTGTAGACCA 
                Mut7  GAGGCATCAA TGAAGTATGG TTCGAGAATC ACACCGTTCC CTGTAGACCA 
                Mut5  GAGGCATCAA TGAAGTATGG TTCGAGAATC ACACCGTTCC CTGTAGACCA 
                Mut8  GAGGCATCAA TGAAGTATGG TTCGAGAATC ACACCGTTCC CTGTAGACCA 
                Mut3  GAGGCATCAA TGAAGTATGG TTCGAGAATC ACACCGTTCC CTGTAGACCA 
                Mut2  GAGGCATCAA TGAAGTATGG TTCGAGAATC ACACCGTTCC CTGTAGACCA 
                Mut6  GAGGCATCAA TGAAGTATGG TTCGAGAATC ACACCGTTCC CTGTAGACCA 
           Consensus  gaggcatcaa tgaagtatgg ttcgagaatc acaccgttcc ctgtagacca 
 
                      1751                                              1800 
                 SPP  .......... .......... .......... .......... .......... 
                Mut1  AATTCTGGAA GTGGAGGATC ATCTTTCTAA AATGTTGGCC AATTGTGAGA 
                Mut4  AATTCTGGAA GTGGAGGATC ATCTTTCTAA AATGTTGGCC AATTGTGAGA 
                Mut7  AATTCTGGAA GTGGAGGATC ATCTTTCTAA AATGTTGGCC AATTGTGAGA 
                Mut5  AATTCTGGAA GTGGAGGATC ATCTTTCTAA AATGTTGGCC AATTGTGAGA 
                Mut8  AATTCTGGAA GTGGAGGATC ATCTTTCTAA AATGTTGGCC AATTGTGAGA 
                Mut3  AATTCTGGAA GTGGAGGATC ATCTTTCTAA AATGTTGGCC AATTGTGAGA 
                Mut2  AATTCTGGAA GTGGAGGATC ATCTTTCTAA AATGTTGGCC AATTGTGAGA 
                Mut6  AATTCTGGAA GTGGAGGATC ATCTTTCTAA AATGTTGGCC AATTGTGAGA 
           Consensus  aattctggaa gtggaggatc atctttctaa aatgttggcc aattgtgaga 
 
                      1801                                              1850 
                 SPP  .......... .......... .......... .......... .......... 
                Mut1  ATTCAAAAAA CGAGCGGCAG GTTAATAATC TAGAAATAGG GATTGAACAA 
                Mut4  ATTCAAAAAA CGAGCGGCAG GTTAATAATC TAGAAATAGG GATTGAACAA 
                Mut7  ATTCAAAAAA CGAGCGGCAG GTTAATAATC TAGAAATAGG GATTGAACAA 
                Mut5  ATTCAAAAAA CGAGCGGCAG GTTAATAATC TAGAAATAGG GATTGAACAA 
                Mut8  ATTCAAAAAA CGAGCGGCAG GTTAATAATC TAGAAATAGG GATTGAACAA 
                Mut3  ATTCAAAAAA CGAGCGGCAG GTTAATAATC TAGAAATAGG GATTGAACAA 
                Mut2  ATTCAAAAAA CGAGCGGCAG GTTAATAATC TAGAAATAGG GATTGAACAA 
                Mut6  ATTCAAAAAA CGAGCGGCAG GTTAATAATC TAGAAATAGG GATTGAACAA 
           Consensus  attcaaaaaa cgagcggcag gttaataatc tagaaatagg gattgaacaa 
 
                      1851                                              1900 
                 SPP  .......... .......... .......... .......... .......... 
                Mut1  AAACTCATCT CAGAAGAGGA TCTGTAGTGA AATCACTAGT GAATTCGCGG 
                Mut4  AAACTCATCT CAGAAGAGGA TCTGTAGTGA AATCACTAGT GAATTCGCGG 
                Mut7  AAACTCATCT CAGAAGAGGA TCTGTAGTGA AATCACTAGT GAATTCGCGG 
                Mut5  AAACTCATCT CAGAAGAGGA TCTGTAGTGA AATCACTAGT GAATTCGCGG 
                Mut8  AAACTCATCT CAGAAGAGGA TCTGTAGTGA AATCACTAGT GAATTCGCGG 
                Mut3  AAACTCATCT CAGAAGAGGA TCTGTAGTGA AATCACTAGT GAATTCGCGG 
                Mut2  AAACTCATCT CAGAAGAGGA TCTGTAGTGA AATCACTAGT GAATTCGCGG 
                Mut6  AAACTCATCT CAGAAGAGGA TCTGTAGTGA AATCACTAGT GAATTCGCGG 
           Consensus  aaactcatct cagaagagga tctgtagtga aatcactagt gaattcgcgg 
 
                      1901                                   1940 
                 SPP  .......... .......... .......... .......... 
                Mut1  CCGCCTGCAG GTCGACCATA TGGGAGAGCT CCCAA..... 
                Mut4  CCGCCTGCAG GTCGACCATA TGGGAGAGCT CCCAACGC.. 
                Mut7  CCGCCTGCAG GTCGACCATA TGGGAGAGCT CCCAACGC.. 
                Mut5  CCGCCTGCAG GTCGACCATA TGGGAGAGCT CCCAACGC.. 
                Mut8  CCGCCTGCAG GTCGACCATA TGGGAGAGCT CCCAAC.... 
                Mut3  CCGCCTGCAG GTCGACCATA TGGGAGAGCT CCCAACGCGT 
                Mut2  CCGCCTGCAG GTCGACCATA TGGGAGAGCT CC........ 
                Mut6  CCGCCTGCAG GTCGACCATA .......... .......... 
           Consensus  ccgcctgcag gtcgaccata .......... .......... 
	 	
 48 
APPENDIX B 
 
GFP expression in Nicotiana Benthamiana to confirm infiltration 
 
 
Leaves infiltrated with the GFP-HA control under ultraviolet light. Fluorescence indicates 
successful infiltration. Samples shown are 48 hours post-infiltration. 
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Certificate of Analysis 
 
 
 
Order Number: U8142BK240-1 
Protein Name: protease 
Shipping Conditions: Dry Ice 
Lot Number: U8142BK240S01/P10011701 
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Certificate of Analysis 
Order Number:  U8142BK240-1 
Protein Name:  protease 
Shipping Conditions:  Dry Ice 
Lot Number:  U8142BK240S01/P10011701 
Expression System &  
Vector: 
 
Purification: 
E.coli, Expression Vector pET30a  
 
 
Protein was obtained from inclusion bodies  
Package: 1.00 mg. 250 μl/tube, 4 tubes; 125 μl/tube, 2 tubes 
Concentration: 0.80 mg/ml, determined by BCATM protein assay with BSA as a standard 
(ThermoFisher, Cat. No. 23225) 
Purity: About 85% under reducing conditions, estimated by densitometric 
analysis of the Coomassie Blue-stained SDS-PAGE gel 
Sterility: Sterilized via a 0.22 μm filter and packaged aseptically 
Storage and Handling: Store at -80°C. Aliquots should be stored at the same temperature after 
first use to avoid multiple freeze-thaws 
Storage Buffer: 1×PBS, 0.3% SDS, pH 7.4 
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SDS-PAGE & Western blot Analysis: 
 
                 SDS-PAGE                         Western blot 
 
                            
 
 
 
 
 
 
 
 
 
Fig.1 SDS-PAGE and Western blot analysis of protease 
Lane M1: Protein Marker, GenScript, Cat. No. M00516 
Lane M2: Protein Marker, GenScript, Cat. No. MM0908 
Lane 1: BSA (5.00 μg) 
Lane 2: protease (Reducing conditions, 5.02 μg) 
Lane 3: protease (Reducing conditions, 150 ng) 
Primary antibody: Mouse-anti-His mAb (GenScript, Cat.No. A00186) 
 
Quantification--BSA Standard Curve:  
	
Sample OD560 Concentration 
protease   0.173 0.80 mg/ml 
  M1    1        2 
120 kDa‐‐‐  
80 kDa‐‐‐ 
60 kDa‐‐‐        
40 kDa‐‐‐ 
30 kDa‐‐‐     
20 kDa‐‐‐    
10 kDa‐‐‐   
120 kDa‐‐‐
85 kDa‐‐‐
60 kDa‐‐‐
40 kDa‐‐‐
22 kDa‐‐‐ 
M2   3
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Packing List of U8142BK240-1 
	
Protein (Shipping Condition: -80°C Dry Ice, Store at -80°C)	
	
Protein name: protease 
Fused with: C-His tag 
Purity: >85% 
Concentration: 0.80 mg/ml 
Lot: U8142BK240S01/P10011701 
Buffer: 1×PBS, 0.3% SDS, pH 7.4 
Total: 1.00 mg. 250 μl/tube, 4 tubes; 125 μl/tube, 2 tubes 
	
	
	
	
	
	
	
	
	
	
	
	
Certified by:		       Date:	01/25/2017 
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Appendix 
DNA Sequence (Sequencing Confirmed): 
	
1    ACCATCCTGA CCGATAAGCT GATTAACATT AGCGCGGTGA TTGTGAACCT GACCCCGACC 
61    CGTCGTGCGT ACATGAACGT GGTGCGTCTG ATCGGTACCA TTGTGGTTTG CCCGGCGCAC 
121    TACCTGGAGG CGCTGGAGGA AGGCGACGAA CTGTATTTCA TCTGCTTTAG CCTGGTGATT 
181    AAGCTGACCT TCGATCCGAG CCGTGTGACC CTGGTTAACA GCCAGCAAGA CCTGATGGTG 
241    TGGGATCTGG GTAACATGGT TCCGCCGAGC ATCGACACCC TGAAAATGAT TCCGACCCTG 
301    GAGGACTGGG ATCACTTCCA GGATGGTCCG GGCGCGTTTG CGGTTACCAA GTACAACAGC 
361    AAATTTCCGA CCAACTATAT CAACACCCTG ACCATGATCG AACGTATTCG TGCGAACACC 
421    CAGAACCCGA CCGGTTGCTA CAGCATGATG GGCAGCCAAC ACACCATTAC CACCGGCCTG 
481    CGCTATCAAA TGTTTAGCCT GGACGGTTTC TGCGGCGGTC TGATTCTGCG TGCGAGCACC 
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Derived Protein Sequence:	
	
Theoretical Isoelectric Point Theoretical Molecular Weight 
6.78 21158.7 Da 
	
1    MTILTDKLIN ISAVIVNLTP TRRAYMNVVR LIGTIVVCPA HYLEALEEGD ELYFICFSLV 
61    IKLTFDPSRV TLVNSQQDLM VWDLGNMVPP SIDTLKMIPT LEDWDHFQDG PGAFAVTKYN 
121    SKFPTNYINT LTMIERIRAN TQNPTGCYSM MGSQHTITTG LRYQMFSLDG FCGGLILRAS 
181    THHHHHH 
 
	
Note: 
	
His tag: 182 ~ 187 
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General Procedure 
1. Gene Synthesis and Subcloning: 
After customer’s approval, target DNA sequence U8142BK240‐1 (protease) was designed, synthesized with 
related tags for each construct to facilitate the purification. The complete sequence was subcloned into target 
vectors for E. coli expression. 
2. Expression Evaluation: 
E. coli BL21 (DE3) was transformed with recombinant plasmids. A single colony was inoculated into medium 
containing related antibiotic; cultures were incubated in 37 qC at 200 rpm. IPTG was introduced for induction. 
SDS‐PAGE and Western blot were used to monitor the expression.   
3. Purification and Analysis: 
Cells were harvested by centrifugation. Cell pellets were lysed by sonication, and then precipitate after 
centrifugation was dissolved using urea. Fractions were pooled and refolded followed by 0.22 μm filter 
sterilization. Proteins were analyzed by SDS‐PAGE and Western blot by using standard protocols for molecular 
weight and purity measurements. The primary antibody for Western blot was Mouse‐anti‐His mAb (GenScript, 
Cat.No.A00186). The concentration was determined by BCATM protein assay with BSA as a standard.	
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Protein Expression & Purification 
Bacterial Expression System   
BacPower™ Guaranteed Package 
x Gene synthesis is included in the package – no additional cost to 
you. 
x Guarantees the amount of custom protein – no cost to you if 
project fails. 
x Guarantees the purity of custom protein – no cost to you if 
desired purity is not achieved. 
x Fast turnaround time ‐ as little as 6 weeks.   
For more details, please visit: 
http://www.genscript.com/guaranteed‐bacterial‐protein‐ex
pression‐services.html 
Mammalian Expression System 
MamPower™ Guaranteed Protein Package     
Guaranteed expression of recombinant proteins in mammalian cells.
x 3 mg protein guaranteed or no cost to you. 
For more details, please visit: 
http://www.genscript.com/bioprocess_promotion_p.html 
MamPower ™ Guaranteed Antibody Package   
Guaranteed  expression  of  recombinant  antibodies  in  mammalian 
cells. 
x 50 mg antibody guaranteed or no cost to you. 
For more details, please visit:         
http://www.genscript.com/bioprocess_promotion_a.html 
Baculovirus Expression System 
InsectPower™ Guaranteed Protein Package 
x Gene Synthesis and Subcloning included. 
x Fast turnaround time: as soon as 12 weeks . 
x 1mg guaranteed protein with ≥ 75% purity or no cost to you. 
For more details, please visit:   
http://www.genscript.com/insectpower_guaranteed_protein_pa
ckage.html 
Expression Evaluation & Optimization 
Systems: E.coli , Baculovirus/Insect, Mammalian 
x Evaluate whether your target protein expresses in 
your chosen expression system.   
x Identify the construct and conditions that gives you 
the most robust soluble expression of your target 
protein.   
x Identify the best expression system for your target 
protein. 
For more details, please visit: 
http://www.genscript.com/protential_protein_expressi
on_evaluation_services_pr.html 
Stable Cell Line Development Service 
Stable  Cell  Line  Development  Services  for 
recombinant protein and antibody production   
For more details, please visit 
http://www.genscript.com/production‐stable‐cell‐l
ines.html 
Large‐Scale Protein Production Service 
Capabilities of Different Expression Systems 
Bacteria  Yeast  Insect Cells  Mammalian Cells
2,000L  2,000L  100L  500L 
Fermentor  Fermentor  Wave™ Mixer  Wave™ Mixer 
For more details, please visit: 
http://www.genscript.com/custom_protein_large_scal
e_expression_purification.html  
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U8142BK240-1 protein sequence coverage report 
 
Sample information (from customer) 
Sample name protease 
Order NO.: U8142BK240-1 
Sample type 5μg in gel 
Theoretical mass or Sequence information: Provided by customer 
 
Processing Settings 
Instrument Name SHIMADZU LC-AB SCIEX Triple TOF 4600  
Operator Peng Liqin 
LC method C18 column,40mins gradient 
Enzyme Trypsin 
MS acquisition method IDA 
Data analysis software Biopharma view 
 
 
 
  
Result Summary 
Protein Name U8142BK240-1  
Protein sequence MTILTDKLINISAVIVNLTPTRRAYMNVVRLIGTIVVCPAHYLEALEEGDELYFICFSLVIKLTFDPSRVTLVNSQQDLMVWDLGNMVPPSIDTLKMIPTLED
WDHFQDGPGAFAVTKYNSKFPTNYINTLTMIERIRANTQNPTGCYSMMGSQHTITTGLRYQMFSLDGFCGGLILRASTHHHHHH 
 
  
% Cov (95) Accession Name Species 
67.4 sp|Sequence_U8142BK240-1 U8142BK240-1 NA 
  
Analysis data and figure 
TIC Spectrum 
 
  
  
Appendix 
Peptide Summary file:  
Peptide Sequence Charge RT Observed Mono m/z Theoretical Mono m/z Error (PPM) XIC Area 
T12 ANTQNPTGCYSMMGSQHTITTGLR 3 14.21 876.0680 876.0651 3.4 6.896e+03 
T14 ASTHHHHHH 2 1.02 550.7476 550.7477 -0.1 6.618e+04 
T4 AYMNVVR 2 9.72 426.7238 426.7235 0.8 1.632e+05 
T10 FPTNYINTLTMIER 2 21.01 856.9381 856.9374 0.7 3.012e+05 
T2 LINISAVIVNLTPTR 2 22.90 812.4937 812.4932 0.5 2.659e+05 
T2 LINISAVIVNLTPTR 3 22.89 541.9977 541.9979 -0.4 1.615e+05 
T2-3 LINISAVIVNLTPTRR 3 22.49 594.0321 594.0316 0.8 1.013e+04 
T6 LTFDPSR 2 10.45 418.2192 418.2191 0.3 2.064e+05 
T8 MIPTLEDWDHFQDGPGAFAVTK 3 21.75 825.7282 825.7265 2.1 1.298e+05 
T1 MTILTDK 2 10.63 411.2255 411.2255 0.1 4.616e+03 
T3-4 RAYMNVVR 2 8.13 504.7741 504.7740 0.1 1.902e+04 
T9 YNSK 1 1.09 511.2506 511.2511 -1.0 1.533e+05 
T13 YQMFSLDGFCGGLILR 3 22.91 626.3072 626.3077 -0.7 7.075e+03 
 
*Raw data are available upon request. 
End of report 
